Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,insulin-like growth factor I binding (GO:0031994),-0.8632279361115219,-2.055707375295502,0.0,0.0021094531013546355,0.002,9/13,11.21%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.8545633858084489,2.0296986235670964,0.0,0.0713106037081514,0.058,7/23,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.8621085288666023,2.013148948863246,0.0,0.05324525076875305,0.085,7/21,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,store-operated calcium channel activity (GO:0015279),0.9327709443185194,2.0005741749334454,0.0,0.045638786373216896,0.105,4/10,1.23%,TRPC3;TRPC4;TRPC6;TRPC1
prerank,retinoid binding (GO:0005501),-0.7526049008188224,-1.9989258662095724,0.0,0.0052736327533865895,0.009,7/22,9.70%,ALDH1A2;RBP1;PTGDS;CYP26B1;RBP4;ABCA4;CRABP2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.7235775339539727,-1.9883626837812685,0.0,0.00492205723649415,0.013,8/25,6.03%,MICAL3;POR;MICAL2;CYP26B1;NOS3;FMO1;FMO2;CYP27A1
prerank,inward rectifier potassium channel activity (GO:0005242),0.8275803723547446,1.9758826454786587,0.0,0.05490916485527657,0.166,3/24,1.12%,ABCC9;KCNJ8;KCNJ12
prerank,glutamate receptor activity (GO:0008066),0.8420920057046324,1.9646157166711857,0.004149377593360996,0.054766543647860266,0.2,7/19,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRID1;GRIA2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.9260205730925605,1.9627493481679712,0.0,0.04690653043913959,0.206,5/12,2.18%,PDE8B;PDE4D;PDE4C;PDE3A;PDE7B
prerank,cation channel activity (GO:0005261),0.6510208987626238,1.949628529160459,0.003067484662576687,0.052430272440659884,0.258,17/94,7.60%,ABCC9;TRPC3;ANO1;TRPC6;CACNB2;TRPC1;KCNG1;TRPV2;KCNQ4;UNC80;SLC24A4;SLC24A2;TMEM38B;RYR2;CHRNA7;CACNA1D;TMEM38A
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.9136435752479,1.9418512813346427,0.0,0.052650995737851786,0.293,7/11,5.56%,TRPC3;TRPC4;TRPC6;TRPC1;ITPR2;ITPR1;RPH3A
prerank,calcium channel activity (GO:0005262),0.6555359814875316,1.9230003848504134,0.0015772870662460567,0.06666220879976818,0.388,12/84,4.64%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;TRPC1;TRPV2;CACNG7;CACNA2D1;STIM2;SLC24A4;SLC24A2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.8144137943235258,-1.9114114965172397,0.0,0.022149257564223673,0.074,7/12,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7350658472380318,1.900493347096401,0.00558659217877095,0.08890055262282873,0.51,9/31,9.95%,ABCC9;SLC12A2;KCNG1;KCNQ4;SLC12A6;TMEM38B;TMEM38A;PKD2;SLC12A5
prerank,cyclic nucleotide binding (GO:0030551),0.8284173587425364,1.896198002162515,0.0,0.0852269760681664,0.53,7/21,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE5A;SLC19A1;PDE4B;POPDC3
prerank,glucuronosyltransferase activity (GO:0015020),-0.7242287864441799,-1.8960593382899218,0.0,0.023414929425036455,0.094,4/19,5.32%,EXT1;LARGE1;CSGALNACT1;CHSY1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7659569758666468,-1.8826232214964542,0.0019267822736030828,0.02548922497470185,0.123,6/15,12.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,intracellular chloride channel activity (GO:0061778),0.8246886147681864,1.880495668106256,0.011904761904761904,0.0931060497645915,0.619,2/16,0.25%,ANO1;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.8246886147681864,1.880495668106256,0.011904761904761904,0.0931060497645915,0.619,2/16,0.25%,ANO1;ANO4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6845171919165524,1.8657088404711464,0.005272407732864675,0.10730547986559924,0.687,15/55,7.39%,TRPC3;CACNB2;ATP2A3;TRPC1;ITPR2;TRPV2;ATP2C1;ATP2B3;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D
prerank,cAMP binding (GO:0030552),0.8706997047610527,1.8381810762026052,0.008421052631578947,0.14598072919099792,0.812,5/11,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE4B;POPDC3
prerank,ion gated channel activity (GO:0022839),0.7555844529703613,1.824074439888055,0.016853932584269662,0.1633012824916667,0.859,2/24,0.25%,ANO1;ANO4
prerank,I-SMAD binding (GO:0070411),-0.7589734946250967,-1.793119469076138,0.0018726591760299626,0.08980243202909735,0.415,6/13,6.13%,SMAD3;SMAD6;TGFBR1;SMAD9;SMAD7;SMURF1
prerank,potassium channel activity (GO:0005267),0.5805814624404938,1.7826618608935543,0.004754358161648178,0.24055443650883068,0.96,18/89,9.03%,ABCC9;KCNG1;KCNMB1;KCNV2;KCNQ4;GRIK1;KCND2;KCNH4;KCNH8;TMEM38B;KCNQ5;HCN2;TMEM38A;KCNE5;KCNA4;KCNQ3;HCN3;PKD2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7543950409314726,-1.7802600365979786,0.0019011406844106464,0.09611195693047059,0.471,6/13,12.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.69385083892943,-1.7796169624554365,0.0056179775280898875,0.08613600163864762,0.473,9/18,11.59%,TGFBR3;SMAD3;SMAD6;TGFBR2;TGFBR1;SMAD7;FKBP1A;USP15;TGFB1
prerank,potassium channel regulator activity (GO:0015459),0.6407462770793773,1.7603450148691366,0.0018018018018018018,0.28117506928777025,0.983,6/49,5.49%,ABCC9;NEDD4L;KCNMB1;KCNE4;DPP10;KCNAB3
prerank,cholesterol transfer activity (GO:0120020),-0.6928088905930463,-1.7524481319572802,0.007575757575757576,0.11369952216301486,0.611,7/16,17.78%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5
prerank,cGMP binding (GO:0030553),0.8371966041106649,1.7482876795367717,0.017467248908296942,0.2955511757897138,0.991,2/11,1.66%,RAPGEF2;PDE5A
prerank,metalloendopeptidase activity (GO:0004222),-0.5018840205196351,-1.7431368515832997,0.0,0.11659522596578352,0.659,25/76,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ADAMTS1;ADAMTS15;ADAMTSL1;ADAMTSL4;MMP14;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,anion channel activity (GO:0005253),0.6143482481050375,1.7376485211100214,0.005008347245409015,0.30616019192033,0.995,7/61,5.87%,ANO1;ANO4;SLC1A4;GPR89A;GPR89B;GABRG2;GABRA2
prerank,leak channel activity (GO:0022840),-0.6707741987959583,-1.7364797020882252,0.007633587786259542,0.11593202669528185,0.69,3/18,2.80%,KCNK2;NALCN;KCNK5
prerank,voltage-gated chloride channel activity (GO:0005247),0.8197273126383222,1.7299260449120464,0.034482758620689655,0.3098728709705322,0.996,1/10,0.04%,ANO1
prerank,sterol transfer activity (GO:0120015),-0.6678062158752647,-1.7252941479980999,0.007561436672967864,0.1222671470669783,0.74,9/17,24.63%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5;OSBP;GRAMD1B
prerank,insulin-like growth factor binding (GO:0005520),-0.6953303616288389,-1.7236984987192359,0.003766478342749529,0.11564323252069164,0.749,9/15,11.21%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,voltage-gated anion channel activity (GO:0008308),0.7737282655435332,1.7235190093616686,0.03036876355748373,0.31035239104741524,0.997,3/15,4.66%,ANO1;GPR89A;GPR89B
prerank,transforming growth factor beta binding (GO:0050431),-0.6385596650350477,-1.7215627582153683,0.0,0.10990250658057653,0.752,13/23,23.75%,TGFBR3;TGFBR2;THBS1;TGFBR1;ACVR1;LTBP4;ACVRL1;TWSG1;LTBP1;CD109;LRRC32;NRROS;LTBP3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.7575167825027015,-1.7109307975313162,0.0055248618784530384,0.11634952262159164,0.789,4/11,2.78%,AKAP13;SH3RF1;IQGAP1;KSR1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.7921800616812815,1.7073944080321533,0.017391304347826087,0.3363380126200115,0.999,7/13,7.50%,PIP5K1B;PIK3CD;PIP4K2A;PIK3CA;PIP4K2C;PIK3C2A;PIKFYVE
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.6658844385016789,-1.705271078968805,0.005964214711729622,0.11682647617208172,0.808,7/18,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,chloride channel activity (GO:0005254),0.603583623180603,1.694304743677265,0.008620689655172414,0.35413638141509185,0.999,7/59,6.37%,ANO1;ANO4;SLC1A4;TTYH2;GABRG2;GABRA2;TTYH1
prerank,diacylglycerol kinase activity (GO:0004143),0.7974205031091837,1.6919963827839808,0.024608501118568233,0.3461701946408501,0.999,3/11,1.88%,DGKB;DGKH;DGKG
prerank,G protein-coupled receptor activity (GO:0004930),0.49798718067795766,1.6912985788829067,0.0,0.3346844334035905,0.999,25/239,6.60%,GRM3;PDGFRB;CYSLTR2;P2RY14;S1PR3;PTH1R;ADGRL3;RORB;ADORA2A;GPR61;GPR152;ADCYAP1R1;FFAR2;GIPR;OPN1MW;OPN1MW3;GRM5;GPR87;XPR1;TAS1R1;GRM1;CXCR2;GPR45;TRHR;OPRK1
prerank,calcium channel regulator activity (GO:0005246),0.6320375611900624,1.689146718553964,0.025362318840579712,0.32732447479865046,0.999,7/37,3.95%,REM1;PRKG1;RRAD;NRXN1;CACNG7;STIM2;ITPR1
prerank,calcium activated cation channel activity (GO:0005227),0.7680008189272565,1.6856090999057973,0.04743083003952569,0.32419158742939114,1.0,2/17,2.25%,ANO1;KCNMB1
prerank,SH2 domain binding (GO:0042169),0.6557580691138709,1.6746062858361532,0.03356890459363958,0.33747128458298953,1.0,4/31,3.87%,DLC1;PTK2;AFAP1L2;PAG1
prerank,frizzled binding (GO:0005109),-0.5585319432688178,-1.672965884309839,0.006276150627615063,0.1542244600768167,0.899,16/34,17.61%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;WNT5A;FZD7;ZNRF3;MYOC;WNT5B;CCDC88C;WNT16;SFRP1;WNT11;FZD1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.6566542517096766,1.670445006347499,0.022,0.3353183054365519,1.0,6/34,5.32%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;OGT
prerank,semaphorin receptor activity (GO:0017154),-0.7261177554223203,-1.668954014671735,0.00909090909090909,0.15221369483985292,0.903,4/11,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,filamin binding (GO:0031005),-0.7254486352737,-1.6684122746704433,0.007312614259597806,0.14523584602826667,0.903,3/11,5.35%,NEBL;DPYSL3;SYNPO2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6395021122843,-1.6607737696105764,0.011428571428571429,0.15047432122996401,0.921,7/18,5.49%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BAIAP2;ANXA1;CNN3
prerank,P-type ion transporter activity (GO:0015662),0.7765085480705575,1.6563858680007097,0.05010893246187364,0.35603160767493397,1.0,5/12,6.59%,ATP2A3;ATP2C1;ATP7A;ATP2B3;ATP2A2
prerank,phospholipase C activity (GO:0004629),0.6753427453618501,1.65087169930432,0.0437375745526839,0.3578009541056496,1.0,3/25,0.48%,PLCL1;EDNRA;PLCE1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3994784099537015,-1.6500763020923834,0.0,0.15979107242761367,0.937,73/254,18.12%,NFIB;SMAD3;ZBTB16;MECOM;NFAT5;FOXO1;FOXO3;NFIA;NR3C1;ERG;HOXB3;MLXIP;ESR1;ELF1;ELF4;MEOX2;KLF4;PLAGL1;TCF4;FOXC2;TFDP2;NFATC1;LEF1;HOXA5;AR;PRRX1;GLIS2;GTF2I;IRF1;SIX1;HLF;PRDM16;FOXC1;IRF2;STAT3;HINFP;NR2C2;PGR;KLF10;TFCP2;RREB1;HIF1A;NR4A2;ATF6;FOSL2;TFCP2L1;CEBPG;NFYC;ELK3;MDM2;ZIC3;RELA;PPARA;MEF2A;CLOCK;MEIS2;ZNF585A;ZNF585B;SOX17;HSF2;CREB3L1;HOXC4;HOXB7;CREB3;NKRF;HHEX;MEIS1;SOX18;ATF1;NFYB;MAFF;SOX12;KLF15
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7939432725515607,1.6396882050091774,0.0392156862745098,0.37372518816098255,1.0,2/10,0.73%,CACNA1C;CACNB2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6671009002108734,1.6317302703904588,0.04380952380952381,0.38205704621990755,1.0,5/27,3.95%,SLC12A2;ATP2A3;ITPR2;ATP2B3;ITPR1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6194163744549026,1.6242491098884784,0.036101083032490974,0.3886903306118971,1.0,7/48,4.78%,ABCC9;TRPC6;SLC12A2;TRPC1;TRPV2;UNC80;SLC12A6
prerank,NAD binding (GO:0051287),-0.5739623463838401,-1.6177728781688234,0.020202020202020204,0.21337576696963304,0.976,11/26,20.05%,ALDH1A1;CRYL1;PARP9;SORD;ME1;NNT;BDH2;SIRT2;SIRT3;HSD17B8;NUDT6
prerank,chemokine binding (GO:0019956),0.6452592253644562,1.6158526808744875,0.035849056603773584,0.3983093387120856,1.0,8/30,8.21%,ITGA4;CCRL2;ACKR3;FGF2;ITGB1;CXCR2;CCR9;ACKR2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5886727625520458,-1.6151244800473377,0.012219959266802444,0.20997847746400936,0.981,8/24,10.42%,PLA2G4A;OSBPL8;CERT1;SESTD1;ARFIP2;GOLPH3;DAB2IP;GSDMD
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.7008195357680622,1.6143666106325958,0.06382978723404255,0.390499435657322,1.0,4/14,9.41%,PTEN;MTMR12;MTMR14;MTMR7
prerank,gap junction channel activity (GO:0005243),0.6809078956230596,1.6121743380692892,0.04216867469879518,0.3853775151975255,1.0,4/22,6.36%,GJD3;GJC1;GJA4;GJC2
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.4982223769082654,-1.6097785578017247,0.017456359102244388,0.21318133042289947,0.985,19/53,18.75%,MICAL3;AOX1;POR;DDO;MICAL2;XDH;NOS3;DPYD;PRODH;AIFM1;ACOX1;ACADL;PPOX;ACOX3;NOS1;SQOR;ILVBL;QSOX1;CYB5R3
prerank,exopeptidase activity (GO:0008238),0.5832950929819382,1.6093007212760746,0.037037037037037035,0.3817616216977582,1.0,9/50,5.29%,ACE2;ENPEP;FAP;NAALAD2;CPM;METAP2;ANPEP;GGH;DPP10
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.6306925413569253,-1.6068624491359713,0.006085192697768763,0.20993114999058154,0.986,5/18,16.31%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2
prerank,wide pore channel activity (GO:0022829),0.6780778540461014,1.6058041538083816,0.04665314401622718,0.37944372233107354,1.0,4/23,6.36%,GJD3;GJC1;GJA4;GJC2
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.4555772100022505,-1.5976229419807388,0.0026666666666666666,0.22203947089073608,0.991,27/78,15.98%,CTSH;CASP12;USP47;CAPN2;CTSC;CFLAR;USP46;CASP4;USP12;USP8;CAPNS1;USP15;USP18;CTSB;CAPN5;CAPN1;USP34;CASP8;USP35;USP11;USP5;GPAA1;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,LRR domain binding (GO:0030275),-0.6736697652954113,-1.597570205558334,0.010183299389002037,0.2141848273982582,0.991,4/14,9.13%,ROBO1;PAWR;ERC1;PMF1
prerank,carboxylic acid binding (GO:0031406),0.6084133472743364,1.597179218148482,0.04804270462633452,0.38943706278731266,1.0,3/38,2.38%,GRM7;UBR1;SESN3
prerank,GTPase regulator activity (GO:0030695),0.47310168019755305,1.5956091122243956,0.008333333333333333,0.3833793885071568,1.0,31/212,5.02%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RGS6;TBC1D1;ARHGAP10;RAPGEF2;ARHGAP32;ARHGEF6;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;WAS;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;WASL;RIMS1;RGS11;RTKN;ASAP2;TBC1D30;RIN2;SYDE1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7613998551886388,1.589166876345213,0.06941431670281996,0.38910161037281865,1.0,4/11,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,phospholipase inhibitor activity (GO:0004859),-0.7040985215814379,-1.57619931586668,0.03518518518518519,0.2486972466735,0.994,4/10,3.96%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6862158522897891,-1.575313514009678,0.02247191011235955,0.24184879807030898,0.994,7/12,13.97%,SULF1;ARSB;SULF2;ARSI;ARSK;ARSG;GALNS
prerank,ion channel activity (GO:0005216),0.5453683384936369,1.5712925405904832,0.035058430717863104,0.420862217521199,1.0,10/80,6.62%,ABCC9;TRPC6;TRPC1;TRPV2;CHRNA3;UNC80;GRIK1;GRID1;GRIA2;CHRNA7
prerank,GTPase activator activity (GO:0005096),0.4476309563725214,1.5674116566500873,0.006527415143603133,0.42059522293761825,1.0,39/313,5.02%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RAPGEF5;RGS6;TBC1D1;PLCE1;ARHGEF17;ARHGAP10;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;ARHGAP32;FARP1;ARHGEF6;RASGRP2;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;RGS11;RALGPS1;CYTH3;ASAP2;EPS8L1;TBC1D30;RIN2;SYDE1
prerank,phosphatidic acid binding (GO:0070300),0.6815522485212486,1.5670439718752676,0.06595744680851064,0.4122372986537309,1.0,3/19,1.89%,PITPNC1;RAPGEF2;MARK1
prerank,potassium ion leak channel activity (GO:0022841),-0.6273160378501657,-1.542430391707591,0.03564727954971857,0.3114505433838764,0.999,2/15,2.80%,KCNK2;KCNK5
prerank,bHLH transcription factor binding (GO:0043425),-0.5870931756666143,-1.5343043055256238,0.045364891518737675,0.3234714490108499,1.0,7/19,16.68%,SMAD3;FHL2;BHLHE40;LMO2;BHLHE41;USF1;USF2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6155909156017881,1.532652162835166,0.07509157509157509,0.484608655837948,1.0,4/27,5.36%,ANO1;XPR1;SLC22A8;SLC26A1
prerank,cytochrome-c oxidase activity (GO:0004129),0.6603159461401535,1.5297230386358884,0.087248322147651,0.48124753252487174,1.0,2/15,1.21%,COX4I2;NDUFA4L2
prerank,FAD binding (GO:0071949),-0.552527412700745,-1.5273325836010552,0.052,0.3319192493570893,1.0,8/24,18.75%,MICAL3;DDO;MICAL2;PRODH;AIFM1;SQOR;QSOX1;CYB5R3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6290112591904348,1.5264738312300394,0.07129094412331406,0.4787221507711028,1.0,11/28,14.69%,CHRNA3;GRIK1;GABRG2;GRID1;GABRA2;CHRNA7;GABRA5;GABRA4;GRIK5;GRIK2;CHRNB2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.523230719003987,1.5244907929654123,0.03980099502487562,0.47397781264684624,1.0,9/73,8.14%,EDNRA;CYSLTR2;PTH1R;ADCYAP1R1;GIPR;SORCS1;NPSR1;OPRK1;GPR37
prerank,leucine zipper domain binding (GO:0043522),-0.6786826165691313,-1.5215783278208004,0.03731343283582089,0.33627164145123895,1.0,3/10,9.13%,PAWR;ERC1;PMF1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6686831114422747,-1.5141359282414497,0.03195488721804511,0.34622152402090584,1.0,4/11,8.73%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,ephrin receptor activity (GO:0005003),-0.5957312623729314,-1.51100206679476,0.055970149253731345,0.33546005536136964,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5957312623729314,-1.51100206679476,0.055970149253731345,0.33546005536136964,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.5271414165075681,-1.510109371622944,0.024,0.32904692784946327,1.0,13/29,20.55%,PTPRJ;NFATC1;ACE;MAPK14;DUSP1;DUSP16;GCH1;DUSP7;MAPKAPK3;DUSP10;TPR;ATF7;CDK5RAP3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6489567876060284,1.5086874725243276,0.0970464135021097,0.501318204892076,1.0,4/16,9.41%,PTEN;MTMR12;MTMR14;MTMR7
prerank,solute:anion antiporter activity (GO:0140323),-0.6378507180677591,-1.5068118275384326,0.040152963671128104,0.32934512651662506,1.0,3/14,2.95%,SLC7A11;SLC26A7;SLC26A2
prerank,AMP binding (GO:0016208),-0.6483981273083608,-1.5030377031257223,0.06284658040665435,0.3302348830170682,1.0,2/11,3.00%,PRKAG2;MPPED2
prerank,poly(A) binding (GO:0008143),0.6247116388652507,1.4874939774069253,0.0968421052631579,0.5439353433615609,1.0,9/21,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;HNRNPU
prerank,R-SMAD binding (GO:0070412),-0.5798660454701596,-1.4837754941439791,0.04331450094161959,0.372241297275629,1.0,5/18,6.13%,LDLRAD4;SMAD3;SMAD6;DDX5;SMURF1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6148019060504535,-1.4683730770274712,0.04770992366412214,0.40672264797071045,1.0,4/13,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6181577899858859,-1.468122300827039,0.06839186691312385,0.398196065667339,1.0,6/12,11.21%,CDH5;ITGA5;VEGFD;VEGFC;DAB2IP;ITGB3
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6030634275269124,-1.4632000298765084,0.07590132827324478,0.40381644256159316,1.0,2/14,1.30%,SLC7A11;SLC1A3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.5466409732494701,-1.461861065621638,0.046242774566473986,0.39856944431706204,1.0,13/22,31.44%,DUSP1;DUSP12;DUSP16;DUSP7;DUSP10;DUSP23;MTMR3;DUSP15;PPM1F;DUSP8;DUSP4;CDKN3;DUSP18
prerank,voltage-gated cation channel activity (GO:0022843),0.478583058440065,1.4615221482306695,0.04292527821939587,0.6038348704937528,1.0,20/97,9.87%,CACNA1C;CACNB2;KCNG1;KCNV2;KCNQ4;CACNG7;CACNA2D1;KCND2;KCNH4;KCNH8;KCNQ5;HCN2;CACNA1D;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;GRIN2B;CACNA1A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6613721746481481,-1.46094930498601,0.07857142857142857,0.39240413452807865,1.0,3/10,8.73%,SLC6A13;SLC6A12;SLC6A1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.6102865196106242,-1.4583047898123893,0.054924242424242424,0.3906078795976467,1.0,8/14,20.86%,ENPP1;FHIT;NUDT4;NUDT3;NUDT12;NUDT13;NUDT6;CILP
prerank,voltage-gated potassium channel activity (GO:0005249),0.4895922357546726,1.4569324945661892,0.06493506493506493,0.6043265532027585,1.0,21/80,12.96%,KCNJ8;KCNJ12;KCNG1;KCNV2;KCNQ4;KCNE4;KCND2;KCNH4;KCNH8;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;KCNJ3;KCNJ6;KCNC4;KCNG2;KCNMA1
prerank,muscle alpha-actinin binding (GO:0051371),-0.5918278389727034,-1.4555871446367807,0.052123552123552123,0.38972146047526895,1.0,5/15,6.00%,PDLIM5;PALLD;SYNPO2;PDLIM7;PDLIM2
prerank,amino acid binding (GO:0016597),0.5768100503628353,1.454059689338173,0.09227871939736347,0.6017231959441516,1.0,1/31,0.09%,GRM7
prerank,chloride channel inhibitor activity (GO:0019869),-0.6519454799319421,-1.4530198247145476,0.07880910683012259,0.389000371915112,1.0,4/10,10.34%,WNK4;STX7;WNK1;STX1A
prerank,C-C chemokine receptor activity (GO:0016493),0.6135781360664812,1.4477887609877624,0.13008130081300814,0.6070569821383917,1.0,5/21,8.21%,CCRL2;ACKR3;CXCR2;CCR9;ACKR2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.6007106727007357,-1.4455090589086776,0.0989247311827957,0.40064842754028596,1.0,6/14,23.72%,CAPN2;CAPNS1;CAPN5;CAPN1;CAPN6;CAPN15
prerank,voltage-gated calcium channel activity (GO:0005245),0.5568085039541315,1.44231359107266,0.08711433756805807,0.6109525547169012,1.0,8/37,9.87%,CACNA1C;CACNB2;CACNA1H;CACNG7;CACNA2D1;CACNA1D;PKD2;CACNA1A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.535041856746437,-1.4394006507330637,0.05714285714285714,0.410143861824168,1.0,7/24,15.00%,DAPK1;CAMK1D;PHKA2;PTK2B;CAMK2A;MKNK2;MAPKAPK3
prerank,BMP receptor binding (GO:0070700),-0.6148039235393234,-1.4371795452277707,0.07303370786516854,0.40797634308314557,1.0,4/12,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6263421796869348,1.436569569918096,0.13016528925619836,0.6161727957651234,1.0,8/19,12.34%,GRIK1;GABRG2;GRID1;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5995539237610052,1.4344001104719932,0.11041666666666666,0.6115468450885715,1.0,2/25,0.90%,ART3;PARP8
prerank,vinculin binding (GO:0017166),0.6606257044725857,1.4323426459646105,0.1391304347826087,0.6069324715604886,1.0,3/11,3.98%,UTRN;DMD;CORO2B
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4807265958228818,-1.4303815753641713,0.04883227176220807,0.4192637541447119,1.0,15/35,22.86%,FOXP1;NR3C1;TAF1;STAT1;H3-3A;KLF10;HDAC1;RELA;POU2F1;PARK7;TBPL1;AGO1;UBTF;PIH1D1;SMARCA4
prerank,death domain binding (GO:0070513),-0.627671708719746,-1.4270549967407296,0.06779661016949153,0.42056244609600013,1.0,9/11,30.76%,DAP;MCL1;IRGM;DAPL1;RIPK1;BCL2L1;RACK1;CRADD;TRADD
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6540311237256605,1.4257114717446915,0.11946902654867257,0.6140349557330964,1.0,4/14,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,phosphatidylglycerol binding (GO:1901611),0.6488948396150983,1.425474819613522,0.125,0.6046985838314232,1.0,1/13,0.15%,PITPNC1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.6098251454380891,-1.424891368355652,0.07393715341959335,0.41876479431164715,1.0,7/12,18.39%,TAF1;STAT1;H3-3A;HDAC1;RELA;POU2F1;TBPL1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6181651269165569,1.4217649834679549,0.11133603238866396,0.6044422600024262,1.0,7/21,16.18%,CHRNA3;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNB2;GRIA1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5937926061443816,1.4188953662568797,0.12550607287449392,0.6030797181101454,1.0,10/22,13.64%,CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;HCN3;SCN9A;PKD2;SCN2B;SCN1A
prerank,voltage-gated ion channel activity (GO:0005244),0.6263902309839856,1.4134986577805195,0.15,0.6070982534768016,1.0,5/14,9.03%,CACNA1H;KCND2;GPR89A;GPR89B;PKD2
prerank,adrenergic receptor binding (GO:0031690),0.6285425230513403,1.4117191424658957,0.12577319587628866,0.602207243678413,1.0,3/16,6.01%,PDE4D;RAPGEF2;UCHL1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6127541450060738,-1.410812064341176,0.09743589743589744,0.4513476260791294,1.0,5/11,15.98%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.30935797097531154,-1.4097773689245663,0.0,0.4462603547839452,1.0,174/732,16.16%,NFIB;FOXP2;PBX1;PKNOX2;FOXN3;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;HMGB2;SOX18;KDM6B
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6198099873098426,-1.406806692076105,0.10326086956521739,0.44662213939025736,1.0,4/11,19.48%,SLC25A20;SLC22A4;SLC22A5;SLC25A29
prerank,alpha-tubulin binding (GO:0043014),0.5599564098498454,1.406256372749616,0.1223021582733813,0.6052106102172204,1.0,3/31,6.30%,DLEC1;ARL4C;SNCA
prerank,C-C chemokine binding (GO:0019957),0.587180139724218,1.4002775878830933,0.14979757085020243,0.6108801892951815,1.0,5/22,8.21%,CCRL2;ACKR3;CXCR2;CCR9;ACKR2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5451654244023724,1.3975046708881718,0.13141683778234087,0.6094955193459409,1.0,14/32,20.95%,KCNG1;KCNQ4;KCNE4;KCNQ5;KCNE5;KCNA4;KCNQ3;KCNC4;KCNG2;KCNS3;KCNH1;KCNC2;KCNC1;KCNB2
prerank,sequence-specific mRNA binding (GO:1990825),0.6703590265776824,1.3971099130833076,0.15578947368421053,0.6018479123246628,1.0,5/10,16.85%,RBM24;DHFR;SSB;LARP6;FMR1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6615034027341435,1.3958892949184696,0.15151515151515152,0.5964110885908414,1.0,4/10,11.93%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5332578449247385,1.3939235819574807,0.125,0.5931061378415191,1.0,4/35,4.62%,PLCL1;PLCE1;PLD6;GPCPD1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.3072913346261681,-1.3938572572089731,0.0,0.4764146199245851,1.0,175/731,16.16%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;TRIM24;THRB;MXI1;HOXA5;CREB3L2;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;CREB3L1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B
prerank,lysophospholipase activity (GO:0004622),-0.5306411086558157,-1.3929033121352272,0.10441767068273092,0.471234244066781,1.0,11/20,24.87%,PLA2G4A;ASPG;PNPLA7;PLA2G6;LYPLA1;MGLL;ABHD16A;LYPLAL1;ENPP2;GDPD3;LYPLA2
prerank,beta-tubulin binding (GO:0048487),0.5586175195187586,1.3914417909966073,0.13333333333333333,0.5910639627901206,1.0,3/31,6.72%,DLEC1;FGF13;APPL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5728175555287378,1.38897856157101,0.138671875,0.5891283766887295,1.0,2/23,0.48%,EDNRA;PLCE1
prerank,sodium channel activity (GO:0005272),0.5290207696639504,1.3870239296230231,0.13358778625954199,0.5857865005408981,1.0,14/37,13.64%,CACNA1H;GRIK1;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SCN9A;PKD2;ASIC3;GRIK5;GRIK2;SCN1A
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6134076456994862,-1.3846271428199075,0.11149228130360206,0.48795799978138665,1.0,5/10,15.98%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,triglyceride lipase activity (GO:0004806),0.5907081915316336,1.3809586745458364,0.15510204081632653,0.5929539251493936,1.0,3/20,6.96%,CEL;LIPC;LIPH
prerank,adenyl ribonucleotide binding (GO:0032559),0.39719678083466714,1.3796345986898142,0.03506493506493506,0.5884143528832607,1.0,48/291,10.42%,MYO1B;PDE4D;KCNJ8;MAP3K20;RAPGEF2;CDK6;RAPGEF4;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;SLC19A1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;PDE4B;SYN1;POPDC3;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MYO6;MARK2;MAP4K4;GCK;MAP4K1;COQ8A;NEK6;ABCF3;DARS2;DYRK3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6084985017963798,1.3794368653440205,0.16468253968253968,0.5813581729998558,1.0,4/19,4.10%,AFAP1L2;NRG1;GRM5;NRG3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.42117331846429334,-1.3791441737338659,0.07209302325581396,0.4969803459917284,1.0,20/54,19.40%,HDAC4;HDAC8;TGM2;HDAC9;ACER2;ASPA;NAAA;ACER3;UPB1;ASPG;GLS;ASRGL1;HINT1;HDAC1;HDAC5;NIT2;SIRT7;SIRT2;NIT1;NGLY1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6252515453788546,-1.3780768761963031,0.10036496350364964,0.4923731405622209,1.0,6/10,23.46%,CXADR;CD47;CD200;SIRPA;DSG2;DSP
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5737938951774091,1.3780664621188603,0.1437125748502994,0.5772247348258128,1.0,2/25,3.22%,ADAP2;NCF1
prerank,neuropeptide receptor binding (GO:0071855),0.6015276752239508,1.377319815552428,0.16227180527383367,0.5719585821418463,1.0,2/14,3.64%,UCN2;NMU
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4913349079696951,1.3757985747776993,0.1295971978984238,0.5684775682275003,1.0,4/55,3.11%,SLC38A11;SLC16A12;SLC16A3;SLC19A1
prerank,carboxypeptidase activity (GO:0004180),0.5410022661828532,1.371283595426347,0.1383177570093458,0.572050184380756,1.0,3/35,0.96%,ACE2;NAALAD2;CPM
prerank,cAMP response element binding (GO:0035497),-0.6185270685351785,-1.3669327342391564,0.10681399631675875,0.5182003384296497,1.0,7/10,28.98%,CREB5;CREB3L2;CREB3L1;ATF7;NR4A3;ATF2;JUN
prerank,mannosyltransferase activity (GO:0000030),-0.5152043465461711,-1.362054149509399,0.09751434034416825,0.5248806113039877,1.0,3/21,4.87%,TMTC1;TMTC4;TMTC2
prerank,poly-purine tract binding (GO:0070717),0.5459902122992242,1.3588715101734752,0.16699801192842942,0.5942321198639257,1.0,10/27,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;DAZAP1;HNRNPU
prerank,death receptor activity (GO:0005035),-0.5984793972657347,-1.3538990165047782,0.14531548757170173,0.5412185468452837,1.0,9/11,35.83%,TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;EDA2R;FAS;TNFRSF14;TNFRSF10B;TNFRSF25
prerank,GTPase inhibitor activity (GO:0005095),-0.5704349012579712,-1.352386416017474,0.12571428571428572,0.5380522205313439,1.0,6/13,20.36%,IQGAP1;SLIT2;CPEB2;IQGAP2;RHOH;PDE6D
prerank,protease binding (GO:0002020),-0.37638648529322183,-1.3514476860851539,0.03273809523809524,0.5332108034210905,1.0,25/99,11.49%,TIMP3;COL1A2;FN1;COL3A1;COL1A1;VWF;LCOR;CCBE1;F3;SLC2A13;DPP4;ANXA2;TIMP2;CFLAR;ITGA3;RNF139;BDKRB2;AMFR;CST3;ADAMTSL4;ECM1;PSAP;BRCA2;ITGB3;ATP9A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6092743969702831,1.3483076616009773,0.17932489451476794,0.6118676181028305,1.0,2/15,4.04%,P2RY14;GPR87
prerank,peptidase inhibitor activity (GO:0030414),-0.4549053907172628,-1.3459730071508946,0.09565217391304348,0.541456867798434,1.0,6/33,7.95%,RECK;CAST;TIMP2;ITIH2;SERPIND1;CST3
prerank,tropomyosin binding (GO:0005523),0.5926069037636945,1.3412140140084952,0.16666666666666666,0.621213235597206,1.0,4/16,5.36%,CALD1;SMTNL2;TMOD1;TMOD3
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6390461650235114,1.3371661586111054,0.19444444444444445,0.6234426268376213,1.0,3/10,5.29%,FAP;NAALAD2;DPP10
prerank,lipoprotein particle binding (GO:0071813),0.5515052065398448,1.3351166409943378,0.1992110453648915,0.6211508769895008,1.0,6/20,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6411225614566375,1.3348087568114528,0.19383259911894274,0.6148162549704452,1.0,3/10,7.15%,PIK3CD;PIK3CA;PIK3C2A
prerank,actin monomer binding (GO:0003785),-0.4876828811491153,-1.3329231259814445,0.12172284644194757,0.5746451598533079,1.0,7/22,13.17%,MTSS1;LIMA1;NOS3;PRKCE;TMSB4X;PFN1;TWF1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4501098222535205,1.3323208411296046,0.1152542372881356,0.6140190184458428,1.0,20/74,15.48%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;ADK;CLP1;PIK3C2A;XYLB;GK;NMRK1;DGKD;COASY;CHKB;PAPSS1;FAM20A;IPMK;FCSK;DGKI;IPPK
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.558149123025388,-1.3319181929053603,0.1337099811676083,0.5696414691869357,1.0,4/11,17.56%,SASH1;DAB2IP;PPEF2;ROR2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.6073245177517013,1.32659030016085,0.18924731182795698,0.6202015261171461,1.0,4/15,7.50%,PIK3CD;PIK3CA;PIK3C2A;PIKFYVE
prerank,sialyltransferase activity (GO:0008373),-0.5072910831314625,-1.3261827460479039,0.14699792960662525,0.5796454844965389,1.0,9/20,11.77%,ST3GAL4;ST3GAL6;ST3GAL1;ST3GAL2;ST6GALNAC3;ST3GAL3;ST6GALNAC2;ST8SIA2;ST6GALNAC6
prerank,metalloexopeptidase activity (GO:0008235),0.48225558053915907,1.3257816125016226,0.15502555366269166,0.6153399830306462,1.0,6/51,3.21%,ACE2;ENPEP;CPM;METAP2;MMP15;ANPEP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.40768020865697097,-1.3199859345339167,0.08314606741573034,0.5906035234525578,1.0,20/53,22.34%,SLC7A11;SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A7;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC17A6;SLC25A22;SLC66A1;SLC7A1;SLC22A2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,ligand-gated channel activity (GO:0022834),0.5349591523069337,1.3188868575426465,0.15863453815261044,0.6242984982896089,1.0,14/29,22.15%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5735091243705893,1.3179941801792383,0.19583333333333333,0.6196201359621825,1.0,6/16,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.285601656119008,-1.3162729813903187,0.0,0.5936827704778692,1.0,198/831,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;AEBP1;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;CUX1;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;OSR1;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;NFATC1;LEF1;KLF2;ETV6;TAF1;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;ZBTB8A;TFCP2;IRF9;ZBTB18;FOXL1;LHX6;RREB1;HIF1A;MKX;TWIST2;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;ENO1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B;MNT;USF2;ZFP69;ZNF436;JUNB;ATF1;NFIL3;NFYB;ZFP14;NFXL1;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15
prerank,FMN binding (GO:0010181),-0.5755855180075279,-1.3150750598699994,0.128060263653484,0.5898030871387562,1.0,2/11,3.16%,POR;NOS3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4105384482799435,1.314701249816417,0.09402985074626866,0.6204427121779147,1.0,16/147,4.79%,RAPGEF5;PLCE1;ARHGEF17;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;FARP1;ARHGEF6;RASGRP2;PREX2;RALGPS1;CYTH3;EPS8L1;RIN2
prerank,iron ion binding (GO:0005506),-0.40730525515341737,-1.3142325425225145,0.0835214446952596,0.5843046310943041,1.0,25/48,35.97%,KDM7A;AOX1;AGMO;EGLN2;EGLN3;FTL;KDM3A;DNAJC24;FTO;ISCA2;TYW5;FTH1;DOHH;TET2;EGLN1;CYP2R1;CDO1;TET1;HIF1AN;ACP5;RIOX1;JMJD6;HAAO;ALOX5;PHYH
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5013235340787878,1.3136012340784324,0.18198529411764705,0.6165439732813393,1.0,4/38,5.06%,SERPINI1;SERPINB8;WFDC3;SERPINA10
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5832050271053828,-1.313045741985419,0.16068052930056712,0.5802502780940502,1.0,7/10,28.90%,USP15;IDE;DNAJB2;ANKRD13D;ANKRD13A;DNAJC2;LAPTM5
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6153701781649434,1.3119539572606314,0.20084566596194503,0.6138555426704883,1.0,4/12,12.24%,OPN1MW;OPN1MW3;RRH;OPN3
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6217564476026558,1.3117364857612726,0.1807511737089202,0.6079780336767134,1.0,4/11,16.93%,SLC5A1;SLC2A9;SLC23A2;SLC23A1
prerank,syntaxin-1 binding (GO:0017075),-0.4891577483930374,-1.3095146768885113,0.14979757085020243,0.5841832877225832,1.0,3/22,3.94%,DAPK1;UNC13B;LRRK2
prerank,ligand-gated ion channel activity (GO:0015276),0.5292273937232449,1.3083188407568436,0.17,0.609370938462799,1.0,14/30,22.15%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3964648679100813,-1.308173806130249,0.07175925925925926,0.5809540648882635,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;NRP2;EPHA7;PDGFRA;NRP1;NTRK3;TEK;FGFR2;EPHB4;IGF1R;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5956609903017447,1.3066544464538281,0.20253164556962025,0.6065675149354502,1.0,6/12,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,Tat protein binding (GO:0030957),-0.6005834142157224,-1.3037750768735554,0.15925925925925927,0.5872058230077132,1.0,6/10,27.17%,MDFIC;ACTB;GABARAPL1;SMARCA4;DLL1;CTDP1
prerank,metallopeptidase activity (GO:0008237),-0.34829227737825824,-1.3022116730630375,0.0392156862745098,0.5843445517061151,1.0,32/113,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;PAPPA;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ACE;ADAMTS1;ADAMTS15;ADAMTSL1;RNPEP;ERAP1;LNPEP;ADAMTSL4;MMP14;ADAM15;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;MPND;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6123516435671226,1.3010220026993304,0.20421052631578948,0.6124249727260985,1.0,7/13,10.19%,PRKAR1B;PKIA;PRKAR2B;RYR2;PRKAR2A;CSK;PRKAR1A
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.39674870186902544,-1.299008518415325,0.09750566893424037,0.5864022371387674,1.0,17/51,16.02%,SLCO2B1;SLC16A2;MCU;SLCO2A1;ANKH;SLCO1C1;SLC20A2;SLC22A6;TMEM241;SLC22A4;SLC7A5;SLC5A6;CLCN3;SLC5A5;MFSD2A;SLC35D2;SLC35E4
prerank,"DNA binding, bending (GO:0008301)",-0.5445145377778824,-1.297605073438097,0.166015625,0.5833654429149835,1.0,6/14,16.15%,FOXD1;LEF1;FOXC1;FOXL1;HHEX;HMGB2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6153143753816113,1.2972110544573174,0.19506726457399104,0.6146173854650545,1.0,3/10,9.61%,APOBEC1;ADARB2;DCTD
prerank,serine-type peptidase activity (GO:0008236),0.4269548500472716,1.2956331077172012,0.1339712918660287,0.6124695302013567,1.0,6/96,3.05%,TMPRSS4;FAP;NAALAD2;TMPRSS7;RHBDD3;RHBDF1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3950843210835101,-1.2948054730542031,0.08037825059101655,0.5853983481628322,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;TEK;TGFBR2;FGFR2;EPHB4;IGF1R;ACVR1;ACVRL1;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,protein tyrosine kinase binding (GO:1990782),-0.3785361504831011,-1.2946503854044362,0.10913705583756345,0.5789580164882623,1.0,10/71,5.09%,EPHA4;CDH5;PTPN14;TJP2;DOCK4;NEDD9;BMPR2;ANGPT1;ACVR1;GAS6
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5566319595239348,-1.2932447620112897,0.15315315315315314,0.5767146665005837,1.0,7/12,32.82%,ENTPD1;ENTPD5;CANT1;ENTPD2;NUDT18;ENTPD3;NUDT5
prerank,G protein-coupled receptor binding (GO:0001664),-0.3435191700048356,-1.2901935240853026,0.05952380952380952,0.5797237807682606,1.0,40/132,22.30%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;CXCL12;ARRB1;PDCD6IP;ACE;WNT5A;ITGB4;GNAS;TULP3;FZD7;GNA14;ZNRF3;MYOC;PTCH1;GRK2;CCL25;WNT5B;S1PR1;CCDC88C;WNT16;SFRP1;REEP1;HOMER1;GNA13;HOMER3;WNT11;FZD1;PPY;AGTR1;TAFA5;NTS;BAMBI;GNAI1;REEP2;CCL19
prerank,phospholipase activator activity (GO:0016004),0.6326963696626341,1.2886350348992734,0.24066390041493776,0.6218653889195246,1.0,3/10,12.53%,ARHGAP6;STX4;SRC
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4626214639252001,-1.285726906876143,0.13671875,0.5863800200606489,1.0,10/26,9.26%,SLC6A13;SLC16A2;SLC6A6;SLC6A12;ABCG2;SLC16A1;SLC16A6;SLC16A11;SLC6A1;SLC5A6
prerank,glycerophospholipid flippase activity (GO:0140333),-0.565973825919619,-1.2826231292955443,0.18359375,0.5886677747392631,1.0,5/11,16.68%,ATP10A;ABCA3;ABCA4;ATP8A1;ATP11A
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4164826740830878,1.280023049988363,0.1567732115677321,0.6348380783192723,1.0,20/100,14.05%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;SNX20;OGT;RPH3A;TTPAL;MYO10;GAP43;PLEKHA5;HIP1;PLA2G4E;PIRT;ARHGAP9;ZFYVE28;ANKFY1;RLBP1;ATG2B
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.3924424149345827,-1.2777682988630397,0.12385321100917432,0.5971627346257046,1.0,8/49,3.96%,ANXA3;PLA2G4A;CPNE8;ANXA4;ESYT2;ANXA5;ANXA2;ANXA1
prerank,sequence-specific DNA binding (GO:0043565),-0.28465188163210625,-1.2776878763446495,0.0,0.5907743627975117,1.0,130/590,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;FLI1;NFAT5;FOXP1;HDAC4;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;FOXO1;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;FOXD1;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;TAF1;THRB;HOXA5;ZNF23;ARNT2;RARG;CREM;GLIS2;SOX13;BHLHE40;TEAD1;SIX1;HLF;KDM5B;TET3;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;BPTF;NR2C2;KLF10;TBX1;SMG6;TFCP2;IRF9;ZBTB18;VSX1;FOXL1;LHX6;UPF3A;HIF1A;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;ZKSCAN3;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;PPARA;MEF2A;USF1;GATA6;ZGPAT;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;SLTM;POU2F1;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;SOX18;CENPB;USF2;JUNB;MYRF;SMG5;FBXL19;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CEBPB;KLF15
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5695823974867332,-1.2758883240612213,0.16512059369202226,0.589741179275999,1.0,5/11,25.14%,LEF1;SRRM2;GATA2;MBD2;ZXDC
prerank,metallocarboxypeptidase activity (GO:0004181),0.520079526467921,1.2736567418858473,0.19298245614035087,0.643135619957338,1.0,2/26,0.96%,ACE2;CPM
prerank,transcription coactivator binding (GO:0001223),-0.4730160441198245,-1.2718054480225462,0.17536534446764093,0.595013209476188,1.0,10/20,15.49%,SMAD3;VGLL4;ESR1;THRB;AR;PGR;AHR;RELA;CDK9;RPL23
prerank,cholesterol binding (GO:0015485),-0.40051459618593893,-1.2705851617085706,0.11162790697674418,0.5919933278056946,1.0,15/47,14.82%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL1A;PTCH1;STARD3;STARD4;OSBP2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.2803209425591014,-1.2667630106464438,0.008333333333333333,0.5966754632952747,1.0,119/597,15.54%,NFIB;BNC2;PBX1;PKNOX2;MAF;SMAD3;FLI1;SMARCA2;SMAD6;NFAT5;FOXP1;HDAC4;GLI2;CUX1;TBL1XR1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;CREB3L2;ZNF23;ARNT2;AR;BRD7;RARG;CREM;YAP1;GLIS2;SOX13;BHLHE40;CENPC;IRF1;TEAD1;SIX1;HLF;KDM5B;PRDM16;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT3;HINFP;NR2C2;KLF10;TBX1;TFCP2;IRF9;ZBTB18;VSX1;LHX6;FOXK1;CARM1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;TGIF1;ESRRG;KLF12;GATA2;CEBPG;NFYC;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;RELA;USF1;GATA6;CLOCK;ZW10;MEIS2;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;CREB3L1;HOXC4;HOXB5;HOXB7;SOX7;BEND3;SNAI1;CREB3;JUND;SREBF1
prerank,MAP kinase activity (GO:0004707),-0.5236346267435219,-1.265150646712327,0.17647058823529413,0.5950855092800651,1.0,4/14,14.53%,MAPK4;MAPK14;MAPK6;MAPK3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5705620483654361,1.2611959894357128,0.22061855670103092,0.6588744340371715,1.0,1/16,0.16%,PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5705620483654361,1.2611959894357128,0.22061855670103092,0.6588744340371715,1.0,1/16,0.16%,PTPRK
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5646815592421262,-1.2576328700477775,0.17985611510791366,0.6112629667306815,1.0,5/11,18.67%,SGMS1;SGMS2;PTDSS2;PIGN;PTDSS1
prerank,phospholipase binding (GO:0043274),0.5861668529520971,1.2568850944681977,0.22828282828282828,0.6628012482434427,1.0,4/13,12.53%,ARHGAP6;WAS;BLNK;SRC
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5714641296973748,1.2552291627304515,0.2406311637080868,0.660523735044482,1.0,1/15,0.22%,NDST3
prerank,titin binding (GO:0031432),-0.5197519125230851,-1.254917105669703,0.1927710843373494,0.6128929885859308,1.0,4/13,16.18%,ACTN2;CALM2;TRIM63;CALM1
prerank,DNA binding (GO:0003677),-0.27116505369558375,-1.2519967627948,0.0,0.6149268866519607,1.0,198/694,24.60%,NFIB;TSHZ2;FOXP2;PBX1;ZNF423;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;HDAC4;DENND4A;GLI2;CUX1;FOXO1;FOXO3;APP;ZIC2;ERG;NUPR1;RARB;MEOX2;FOXD1;DNMT3A;PLAGL1;TCF4;TCF7L2;FOXC2;LEF1;KLF2;TAF1;THRB;HOXA5;DDX60;HDGFL3;SSBP2;QRICH1;RARG;CREM;SOX13;THRAP3;CENPC;PDS5B;IRF1;TEAD1;SIX1;INO80;ZNF292;HLF;KDM5B;PRDM16;FOXC1;IRF2;SSBP1;CHD3;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;RAD51B;ZNF219;TBX1;RTF1;POLR2A;RC3H2;ERCC5;TFCP2;ZBTB18;DCLRE1C;AIFM1;FOXL1;REXO4;HIF1A;PCBP2;TRIM16;NHEJ1;NR4A2;ATF6;SAMHD1;IKZF1;ZC3H12A;PRDM5;ZKSCAN3;KLF12;BRCA2;NABP1;CEBPG;PATZ1;NFYC;DNASE1L1;AHR;LRRFIP1;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;CALR;ZGPAT;RPS27;TDG;CLOCK;XRCC4;SPHK1;MEIS2;EZH1;RFX2;RPL7;DDB1;RPA1;SLTM;POU2F1;ZBTB4;RAD50;CDK9;RPS15;TAF4B;SREBF1;APLP2;XRN1;CEBPZ;HHEX;MEIS1;GTF3C2;HMGB2;SPO11;GTF3C5;CENPB;USF2;JUNB;MYRF;TSHZ1;PSIP1;HMGN1;NFYB;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;DEDD;CEBPB;PARK7;SIRT3;YAF2;MCMDC2;RFC3;PPARGC1A;E2F1;SMARCAD1;GTF3C1;CTCF;POU2F2;POLRMT;SMC1A;HP1BP3;NFATC2;RAD52;THAP1;TOP3A;CHRAC1;GLI1;FOXD2;NR5A2;DEDD2;RFC1;SP7;XBP1;DNMT1;ZMYND11;TOP2A;RAD51C;NEIL3;ZNF513;NR4A3;MCM8;LYAR;HDGFL2;SMARCA4;WBP11;RAD51;CDC45;ERCC1;CBFB;ERCC2;MSH6;SATB1;BRCA1;PAX3;RNF11;FOXL2;EGR1;RPA3;POLR2G
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5921693440118827,1.2501837642181939,0.26434426229508196,0.6657212213811399,1.0,3/10,9.84%,NCF2;NCF1;NOX3
prerank,steroid hydroxylase activity (GO:0008395),0.5505606360768152,1.2491460457848171,0.23790322580645162,0.6620793384281257,1.0,1/16,0.61%,CYP7B1
prerank,neuropeptide receptor activity (GO:0008188),0.5044088282704684,1.2489737713751623,0.22179732313575526,0.6566093623579725,1.0,10/29,18.50%,TACR2;SORCS1;TACR1;NPSR1;GPR37;NPY1R;NTSR1;TACR3;NPY2R;SSTR2
prerank,CARD domain binding (GO:0050700),-0.511732884956543,-1.248929522136605,0.18525519848771266,0.6179642860418405,1.0,6/14,10.94%,NOD1;CASP4;CARD14;IRGM;CARD10;MAVS
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4176635761448076,1.2477141581338425,0.1737704918032787,0.6537688834119112,1.0,4/72,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,adenylate cyclase binding (GO:0008179),0.6104767283529706,1.2477050704274062,0.2375,0.6480590899095989,1.0,4/10,8.30%,CAP2;AKAP6;CAP1;AKAP12
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.534029019680249,-1.2444182237878911,0.21526418786692758,0.6252753163203474,1.0,6/13,19.48%,SLC7A2;SLC7A7;SLC38A5;SLC66A1;SLC7A1;SLC25A29
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3255368355876949,-1.2443752736993208,0.096875,0.619258911180515,1.0,29/134,11.62%,ABCC4;SLC6A13;SLC13A3;SLC1A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLCO2A1;SLC26A2;GJA1;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SFXN2;SLC16A11;SLC6A9;SLC7A5;SLC25A17;SLC6A1;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC25A24;SLC3A2;SLC38A6
prerank,active ion transmembrane transporter activity (GO:0022853),0.4778923036631154,1.2442953500905471,0.22444889779559118,0.6498400962612503,1.0,6/37,5.05%,SLCO3A1;COX4I2;NDUFA4L2;SLCO5A1;UQCRFS1;SLC22A8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5658484214165729,-1.2429395649797677,0.2168458781362007,0.617117432782219,1.0,3/10,10.03%,MECOM;PRDM16;EHMT1
prerank,SH3 domain binding (GO:0017124),0.44851542022351365,1.2422828538718793,0.21514629948364888,0.6485330559306154,1.0,8/62,3.66%,SGIP1;AFAP1L2;VASP;WAS;PTPN22;WIPF1;NCF1;ABI2
prerank,kinesin binding (GO:0019894),0.48584566812672636,1.240719460936115,0.22900763358778625,0.6463706892010194,1.0,6/27,9.94%,CLSTN1;TOR1B;AP1G1;AP1AR;SNCA;NEK6
prerank,lipase activator activity (GO:0060229),0.6073160434385851,1.2365893212146997,0.2802547770700637,0.6501673788256529,1.0,1/10,1.07%,ARHGAP6
prerank,exoribonuclease activity (GO:0004532),-0.5243608046221092,-1.236297436955045,0.2029520295202952,0.6301281228195557,1.0,4/12,23.73%,CNOT7;ZC3H12A;EXOSC5;EXOSC7
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.51383310134834,1.2345206353580174,0.2441860465116279,0.6489864186212433,1.0,4/22,3.60%,RBMS3;CPEB1;RBM24;ELAVL4
prerank,ATP binding (GO:0005524),0.35782663577645113,1.2317908947780298,0.11140583554376658,0.6496633699824953,1.0,45/266,12.09%,MYO1B;KCNJ8;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;SYN1;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MARK2;MAP4K4;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;BRSK1;LATS2;SRR;NLK;PFKM
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5476365413233775,-1.2306001423653405,0.20593692022263452,0.6401185661134484,1.0,6/10,28.90%,IDE;PML;DNAJB2;ANKRD13D;ANKRD13A;LAPTM5
prerank,thioesterase binding (GO:0031996),0.5749803616540322,1.2298331905086763,0.25210084033613445,0.6485453847326244,1.0,8/11,26.98%,TRAF5;TRAF3;TRAF6;TRAF2;ARF6;TRAF1;HAUS7;CDC42
prerank,aminopeptidase activity (GO:0004177),0.49420114894104183,1.229203323067757,0.27307692307692305,0.644453019806639,1.0,4/26,3.21%,ENPEP;METAP2;MMP15;ANPEP
prerank,ADP binding (GO:0043531),-0.44837483765317676,-1.2288249566873954,0.1879049676025918,0.6395324489781439,1.0,7/25,11.52%,PRKAG2;MYO18A;ME1;MYH10;GCLC;MYO9B;ERN1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.433790202731184,-1.2278137693566322,0.188212927756654,0.636749261627128,1.0,6/27,11.28%,SLC9A2;SLC41A1;SLC8A3;SLC9B2;SLC9A9;SLC3A2
prerank,cadherin binding (GO:0045296),0.3472977774011539,1.2264806323304613,0.11450381679389313,0.6452585391144195,1.0,34/315,7.14%,NOTCH3;TRPC4;MYO1B;CALD1;COBLL1;CDH2;CDH4;CEMIP2;VCL;PHLDB2;MPRIP;ARHGAP1;VASP;TNKS1BP1;MYH9;CD46;EFHD2;CDC42EP1;SPTBN1;CTNNA3;EPS8L1;TMOD3;ITGB1;CDH8;ANK3;CHMP2B;DDX3X;PDLIM1;CDH22;YWHAZ;CDH19;CDH7;CDH20;WASF2
prerank,ubiquitin-specific protease binding (GO:1990381),0.5266801284377824,1.2244765710095267,0.2551440329218107,0.6442567993723214,1.0,3/19,6.52%,PTEN;DERL3;SART3
prerank,phospholipase activity (GO:0004620),0.42792302704733054,1.222550147518973,0.20695364238410596,0.643164596964559,1.0,7/67,7.19%,PLCL1;PLCE1;PLD6;LIPC;LIPH;ABHD3;PLAAT1
prerank,pentosyltransferase activity (GO:0016763),0.47602042861049554,1.2220859370500143,0.23210831721470018,0.6389731936075584,1.0,2/36,0.90%,ART3;PARP8
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5611588647214216,1.2217356976346023,0.29148936170212764,0.6346082229208875,1.0,4/12,10.61%,PIK3R1;SH2B3;IRS1;BLNK
prerank,fibroblast growth factor binding (GO:0017134),-0.4501973568851259,-1.21853882363093,0.232,0.6581884315689677,1.0,7/21,15.24%,FGFR2;THBS1;KL;RPS19;ITGB3;FGFR4;GLG1
prerank,actin binding (GO:0003779),0.36975435137809776,1.2156048946884843,0.16361071932299012,0.6421742709555621,1.0,30/170,8.41%,EPS8;CALD1;CAP2;UTRN;DMD;SYNE1;PTK2;VCL;MYH9;FERMT2;SPEF1;SSH2;CORO7;NCALD;ADCY8;TMOD1;CORO2B;FMN2;EPS8L1;ACTN4;SPTB;ITGB1;RUSC1;SNCA;PDLIM1;SMTN;CAP1;MYL3;MYO6;CORO1A
prerank,phosphatidylinositol binding (GO:0035091),0.4072020574680027,1.2142595206714113,0.18662519440124417,0.6400043763499951,1.0,12/91,6.72%,PITPNC1;PIGU;SCARB1;ITPR2;NCF1;EPB41;MREG;ITPR1;PITPNM2;RPH3A;WDFY3;APPL1
prerank,5'-nucleotidase activity (GO:0008253),-0.5040302841038625,-1.2121985357138936,0.2342007434944238,0.6714931099472704,1.0,9/13,40.11%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.30360575692271213,-1.2082997966075535,0.10227272727272728,0.6771632108044021,1.0,49/188,18.15%,BNC2;PBX1;SMAD3;FLI1;SMARCA2;SMAD6;HDAC4;TBL1XR1;FOXO3;KLF4;TCF7L2;FOXC2;CREB3L2;AR;BRD7;YAP1;GLIS2;SOX13;IRF1;SIX1;PRDM16;FOXC1;CHD3;STAT3;HINFP;VSX1;FOXK1;CARM1;ATF6;PRDM5;NFYC;AHR;RELA;GATA6;HDAC5;ZNF568;TAL1;SOX17;CREB3L1;SOX7;JUND;HHEX;HMGB2;SOX18;NFYB;SOX12;CEBPB;KLF15;BASP1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33491629130054273,1.208224735448012,0.12,0.6480707664996799,1.0,59/431,10.74%,MYO1B;RASL12;REM1;KCNJ8;RERG;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;RND3;AGAP2;RRAD;AKT3;RPS6KA4;NOA1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;RAC3;MINK1;CLP1;RIT2;TUBA8;SYN2;ARL4C;RRM1;SYN1;SIK1;MCM6;LIG4;RAP1A;HRAS;PAPOLA;HSPA14;TUBB2B;RAB28;PEX1;STK3;RAB38;MARK2;MAP4K4;RNF112;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;TUBG2;ARL5C;BRSK1
prerank,ligand-gated cation channel activity (GO:0099094),0.41451507130838955,1.2055976276364782,0.22366288492706646,0.6486035093304359,1.0,18/75,16.32%,KCNJ8;KCNJ12;CHRNA3;GRIK1;ASIC2;GRIA2;CHRNA7;KCNJ3;GRIN2B;KCNJ6;ASIC3;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;P2RX5;GRIA4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.44239522359849914,1.2042117508916457,0.23036649214659685,0.646729550902664,1.0,2/47,1.78%,SLC38A11;SLC1A5
prerank,GDP binding (GO:0019003),0.42559916109454754,1.2029209565195502,0.23129251700680273,0.6443761980789909,1.0,8/63,7.87%,RASL12;RERG;RAB8B;RIT2;RAB3B;RAP1A;HRAS;RAB28
prerank,monocarboxylic acid binding (GO:0033293),-0.46760499912023545,-1.2025047240145406,0.2540834845735027,0.6885844049363351,1.0,5/18,26.97%,CYP26B1;PSAP;RARA;RXRA;PYGL
prerank,chemokine receptor activity (GO:0004950),0.5054871095428791,1.2022172136536549,0.2556237218813906,0.640958154643257,1.0,5/24,8.21%,CCRL2;ACKR3;CXCR2;CCR9;ACKR2
prerank,calcium ion binding (GO:0005509),0.33950214253392863,1.2013183122419433,0.14035087719298245,0.6379922011755944,1.0,60/323,11.73%,ASPN;CASQ2;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;RASGRP2;CEMIP2;SLIT1;SLIT3;ITPR2;RASGRP3;CIB3;EFHD2;NRXN1;PVALB;STIM2;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;RYR2;ATP2A2;CDH22;CDH19;CDH7;CDH20;AOAH;PADI2;STIM1;SYT1;RYR3;LETM1;PKD2;BNIP2;HPCA;CDH10;CDH18;SPOCK1;BAIAP3;ASAH2;PLA2G4E;KCNIP1;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR
prerank,histone acetyltransferase activity (GO:0004402),-0.41437580822307,-1.2001096570579906,0.21822033898305085,0.6896028201160592,1.0,15/30,25.98%,KAT6B;KAT2B;TAF1;KAT14;ARRB1;BAZ1A;TADA2A;BRCA2;CLOCK;NAA40;USP22;MCM3AP;HAT1;ATF2;EPC1
prerank,manganese ion binding (GO:0030145),-0.37379929283616076,-1.1993681310462072,0.17814726840855108,0.685469585444173,1.0,21/48,30.13%,LARGE1;B4GALT1;XPNPEP1;MPPED2;PPM1M;ME1;MGAT1;MTPAP;MGAT2;ADCY2;FAM20C;NUDT16;MPPE1;HMGCL;XXYLT1;SOD2;ABL1;ATP13A2;ENDOU;POMGNT1;WRN
prerank,chloride channel regulator activity (GO:0017081),-0.4926773352203595,-1.198037303636801,0.23948811700182815,0.6832407571440225,1.0,4/14,10.34%,WNK4;STX7;WNK1;STX1A
prerank,sodium:proton antiporter activity (GO:0015385),-0.5321088366873096,-1.1979212228404574,0.2608695652173913,0.677620536901672,1.0,3/11,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.41702590275789947,1.1945788112780098,0.23089983022071306,0.6474233780777803,1.0,6/60,4.23%,PTEN;CTDSPL;PHLPP1;PPM1E;PPP3CA;LRRC40
prerank,metalloaminopeptidase activity (GO:0070006),0.5363075990046973,1.1945499187431057,0.28125,0.6427462414228046,1.0,3/16,3.21%,ENPEP;MMP15;ANPEP
prerank,double-stranded DNA binding (GO:0003690),-0.2671593912127362,-1.19416862408139,0.014492753623188406,0.6826444825151007,1.0,99/531,15.54%,NFIB;PBX1;PKNOX2;MAF;FLI1;EGFR;NFAT5;FOXP1;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;ZNF23;DDX60;HDGFL3;ARNT2;RARG;CREM;GLIS2;BHLHE40;TEAD1;SIX1;HLF;KDM5B;IRF2;GLIS1;HIVEP1;STAT1;NR2C2;RAD51B;KLF10;TBX1;ERCC5;TFCP2;IRF9;ZBTB18;VSX1;LHX6;REXO4;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;USF1;GATA6;TDG;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;HOXC4;RAD50;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5074258918977749,-1.1938760450771733,0.26429980276134124,0.6775491243496343,1.0,5/12,8.57%,IGF1;SOCS2;IGF2;ARRB1;GNAS
prerank,transmitter-gated ion channel activity (GO:0022824),0.4888853155812405,1.1908600069247162,0.26627218934911245,0.64555732609072,1.0,12/29,18.55%,GRIK1;GABRG2;GRID1;GRIA2;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2;GABRB3;GRIA4;GRID2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.38328163987164204,1.1905985802823644,0.22770700636942676,0.6414328950523523,1.0,4/91,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,serine-type endopeptidase activity (GO:0004252),0.400809230766273,1.1894507241219654,0.22061191626409019,0.6391263793488574,1.0,4/80,3.05%,TMPRSS4;FAP;RHBDD3;RHBDF1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5597844942853144,1.187689618599618,0.2923076923076923,0.6381877574410826,1.0,3/12,7.15%,PIK3CD;PIK3CA;PIK3C2A
prerank,peptide hormone receptor binding (GO:0051428),0.558268572281813,1.1867650584852913,0.30105263157894735,0.635729010184669,1.0,2/11,7.60%,UCN2;CCK
prerank,GABA-A receptor activity (GO:0004890),0.5094839123708682,1.186397854673795,0.27218934911242604,0.631888412438617,1.0,6/18,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.3457707052935378,-1.1855829180971817,0.18652849740932642,0.6957888041048683,1.0,11/70,11.41%,GXYLT2;EXT1;LARGE1;B4GALT1;CSGALNACT1;CHSY1;HEXA;HEXB;B3GALNT1;POGLUT1;POGLUT2
prerank,BMP binding (GO:0036122),-0.5264803266449162,-1.1829472005367947,0.28677839851024206,0.6979719423469589,1.0,3/11,6.39%,BMPR2;GREM2;NBL1
prerank,pyrophosphatase activity (GO:0016462),-0.3697947513027477,-1.182759523038018,0.20601851851851852,0.6927356090969401,1.0,27/50,33.34%,ENTPD1;ENPP1;ENPP3;NUDT4;ALPL;NUDT3;PLPP1;ENTPD5;LHPP;ENTPD2;DOLPP1;NUDT6;PLPP4;CILP;PPA1;NUDT16;NUDT1;CILP2;TRPM2;BNIPL;DXO;ENTPD3;NUDT5;NUDT10;NUDT9;DHX29;FITM2
prerank,cysteine-type peptidase activity (GO:0008234),-0.33871550203126544,-1.1812936325328667,0.17974683544303796,0.6913776123431582,1.0,21/73,15.98%,CTSH;USP47;CAPN2;CTSC;USP46;CASP4;USP12;USP8;USP15;USP18;CTSB;USP34;CASP8;USP35;USP11;USP5;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5156321623696096,-1.1784557721464948,0.28771929824561404,0.6940965233416323,1.0,3/11,10.56%,KCNK2;KCNQ1;KCNT1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.39912896461455644,-1.177424697375761,0.22954545454545455,0.6855297286438583,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.39912896461455644,-1.177424697375761,0.22954545454545455,0.6855297286438583,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4758127361067894,-1.1769758168903899,0.27380952380952384,0.6813955407995744,1.0,4/14,6.06%,TIMP3;RECK;TIMP2;SPOCK2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3810304564522872,-1.176571404238156,0.20823798627002288,0.6772516373738022,1.0,10/42,7.45%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BSG;BAIAP2;ANXA1;PALLD;CNN3;CD47
prerank,NADP binding (GO:0050661),-0.4006127814585808,-1.172814283015568,0.23655913978494625,0.6825243473568032,1.0,13/32,27.28%,GMDS;LBR;NOS3;DPYD;ME1;NNT;PGD;NOS1;NOX1;DECR1;ME3;GRHPR;MTRR
prerank,ATPase binding (GO:0051117),-0.33880261875033335,-1.1714451122430485,0.17357512953367876,0.6809001489228032,1.0,19/71,11.80%,ABCA1;EGFR;ATP1B3;TMTC4;SNTA1;PTPN3;CAV1;SLC2A13;ESR1;EZR;ATP6V0A4;AR;PGR;ATP6V1G1;TOR1AIP1;CHMP4A;NOP58;ATP6V0A1;TCIRG1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5258552575623299,-1.1696311008348195,0.29182156133828996,0.6805112057319679,1.0,1/10,0.92%,KDM7A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.4044159083983855,-1.1694258142971292,0.25,0.6758768869551843,1.0,16/29,33.63%,ACER2;ACER3;CTBS;PGGHG;ADPRS;GANAB;GAA;NEU3;HEXD;MOGS;ENGASE;GLA;HPSE;HYAL3;GALC;LCT
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4081053206896299,1.16872846095559,0.2636986301369863,0.6643176990445203,1.0,6/71,2.78%,PTPRK;PTEN;PALD1;PTPN9;TNS2;PTPN22
prerank,transcription cis-regulatory region binding (GO:0000976),-0.26851811648360957,-1.1673160809960836,0.07514450867052024,0.6765386458039211,1.0,91/406,18.15%,BNC2;PBX1;FOXN3;AEBP1;SMAD3;FLI1;SMARCA2;SMAD6;FOXP1;HDAC4;CUX1;TBL1XR1;OSR1;FOXO3;NR3C1;MLXIP;KLF4;PLAGL1;TCF7L2;FOXC2;TFDP2;LEF1;ETV6;MXI1;CREB3L2;AR;BRD7;CREM;YAP1;HIF3A;GLIS2;SOX13;IRF1;TEAD1;SIX1;PRDM16;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;KLF10;ZBTB8A;TFCP2;VSX1;LHX6;RREB1;HIF1A;TWIST2;FOXK1;CARM1;ATF6;FOSL2;PRDM5;NFYC;GLI3;ELK3;AHR;HDAC1;RELA;MEF2A;GATA6;HDAC5;ZNF568;TAL1;SOX17;HSF2;CREB3L1;ENO1;ZBTB4;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;HMGB2;SOX18;MNT;ZFP69;ZNF436;ATF1;NFIL3;NFYB;NFXL1;SOX12;CEBPB;KLF15;PARK7;BASP1
prerank,symporter activity (GO:0015293),-0.524957347315068,-1.1665880744884287,0.301498127340824,0.6735068254287206,1.0,3/10,13.16%,SLC5A6;SLC5A5;MFSD2A
prerank,lipase activity (GO:0016298),0.44188839126306995,1.1657318501912517,0.2751798561151079,0.6664246405023572,1.0,5/43,7.17%,CEL;PLA1A;LIPC;LIPH;ABHD3
prerank,phospholipid transfer activity (GO:0120014),0.49251493416799474,1.1592574284701944,0.28336755646817247,0.6755621438963548,1.0,3/21,6.57%,PITPNC1;PITPNM2;PRELID3A
prerank,histone deacetylase activity (GO:0004407),-0.45659645249773634,-1.1588232216623222,0.2780952380952381,0.6898546063415028,1.0,8/19,18.47%,HDAC4;HDAC8;HDAC9;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3
prerank,Wnt-activated receptor activity (GO:0042813),0.5197562277684065,1.1587781325129713,0.3081761006289308,0.6719108230209955,1.0,4/15,4.94%,ROR1;FZD6;RYK;TSPAN12
prerank,myosin binding (GO:0017022),0.4195206790151341,1.1571885831156878,0.27627118644067794,0.6708079276387691,1.0,12/55,12.66%,CALD1;DMD;RAB39B;RAB3B;ARFGEF1;KIRREL1;CORO1A;NKD2;TRAK1;STXBP5L;TRAK2;NPHS1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4993186144384012,-1.1568758108907284,0.30925925925925923,0.6902162032007014,1.0,6/12,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,ionotropic glutamate receptor activity (GO:0004970),0.49985508183560245,1.156488991728326,0.31956521739130433,0.6677544075017527,1.0,8/17,16.32%,GRIK1;GRIA2;GRIN2B;GRIK5;GRIK2;GRIN2A;GRIA1;GRIA4
prerank,protein kinase C activity (GO:0004697),-0.4868059648836742,-1.1553362735575576,0.3025210084033613,0.6892052049481452,1.0,6/14,10.98%,PRKCH;PRKCE;PRKCZ;PRKCB;PRKCD;PRKCG
prerank,proton transmembrane transporter activity (GO:0015078),0.430648187441481,1.1547649682713073,0.299412915851272,0.6668460561159949,1.0,6/39,11.86%,COX4I2;NDUFA4L2;UQCRFS1;ATP6V1B2;COX4I1;COX5A
prerank,WW domain binding (GO:0050699),0.47119146781279153,1.153656641933084,0.27325581395348836,0.6647155744327596,1.0,2/26,3.18%,RAPGEF2;NDFIP2
prerank,disordered domain specific binding (GO:0097718),-0.4227267541203477,-1.1536324061741363,0.27720739219712526,0.6887674589614261,1.0,9/23,21.23%,FN1;CALM2;MDM2;HSP90AB1;CALM1;PPIL1;NUMA1;TEAD2;DFFB
prerank,cation:chloride symporter activity (GO:0015377),0.5511943555702847,1.1530887987462017,0.3111111111111111,0.6614934238187106,1.0,4/10,13.23%,SLC12A2;SLC12A6;SLC12A5;SLC12A4
prerank,NAD+ binding (GO:0070403),-0.4981579950887803,-1.1528542295086193,0.29981378026070765,0.6858263161604927,1.0,4/12,18.47%,CRYL1;PARP9;SIRT2;SIRT3
prerank,syntaxin binding (GO:0019905),-0.34901595347011555,-1.152219393280283,0.2216624685138539,0.6825991519387096,1.0,19/61,21.45%,DAPK1;UNC13B;ABCA1;RAB11A;LRRK2;STX7;SNAP23;STXBP4;STX6;SCFD2;SNAP47;NAPA;BLOC1S6;SYT9;VPS52;PTPN2;TMED9;UNC13C;VAMP8
prerank,transcription coregulator binding (GO:0001221),-0.3550704670279013,-1.1514026388852705,0.23486682808716708,0.6798888753038731,1.0,19/50,20.84%,SMAD3;ZBTB16;LCOR;VGLL4;ESR1;THRB;AR;LMO2;PGR;EHMT1;USP11;AHR;RELA;CDK9;RPL23;EZH2;CIT;CTCF;TEAD2
prerank,endopeptidase activity (GO:0004175),-0.27662651982409486,-1.1504604633879922,0.10176991150442478,0.6776241400047954,1.0,57/257,16.09%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;CTSH;PCSK5;ADAMTS9;F3;HTRA3;ADAMTS5;DPP4;USP47;ADAM9;CTSC;USP46;ADAM10;CASP4;ACE;ADAMTS1;USP12;ADAMTS15;ADAMTSL1;USP8;KLK2;USP15;ADAMTSL4;PIK3IP1;USP18;MMP14;CTSB;USP34;CASP8;IDE;MMP19;USP35;USP11;USP5;ADAMTS14;RHBDF2;CTSS;ADAMTS3;USP49;PSMB4;PREP;SPG7;RHBDL3;SFRP1;PSMB1;ADAM33;MMP2;PDIA3;CASP6;AFG3L2;ADAMTSL5
prerank,MAP kinase kinase activity (GO:0004708),-0.4586898953137909,-1.1495647569196232,0.3076923076923077,0.6750848350746566,1.0,5/15,15.00%,LRRK2;MAP2K6;MAPK14;MAP2K5;MAPKAPK3
prerank,guanyl ribonucleotide binding (GO:0032561),0.3420762288566396,1.1456672954505134,0.24104683195592286,0.6724201527697696,1.0,22/196,8.87%,RASL12;REM1;RERG;RAPGEF2;PDE5A;RND3;AGAP2;RRAD;RAB8B;SLC19A1;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAB3B;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,tubulin binding (GO:0015631),0.32866566282297366,1.1443825966198673,0.21638924455825864,0.670504897203917,1.0,42/295,11.89%,DLEC1;SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;NCALD;SVBP;FGF13;IFT81;NAV3;GAS8;CLASP2;MAPRE2;ARL4C;SNCA;DDX3X;TPPP;APPL1;KIF26B;HOOK3;TTLL11;FAM161A;MAP4K4;CLIP2;TTLL12;NUSAP1;KIF3A;UXT;BRSK1;ARHGEF7;TOGARAM2;MACO1;TPGS1;CCDC66;PAK1;KIF20A;KIF5C;APC;KIF3C
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5144491303525245,1.1416111483924996,0.31611570247933884,0.6717550882990065,1.0,3/17,5.15%,PITPNC1;PITPNM2;ATP8B2
prerank,sterol binding (GO:0032934),-0.346860094378614,-1.1414093457122554,0.23820754716981132,0.6917074982984219,1.0,17/56,14.82%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL9;OSBPL1A;INSIG2;PTCH1;STARD3;STARD4;OSBP2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3693063838797066,-1.1387285209316595,0.26096491228070173,0.694142833128278,1.0,12/38,20.78%,PLA2G4A;SESTD1;WIPI2;ZFYVE19;PARD3;DAB2IP;PLEKHA4;SNX21;ATG2A;ZFYVE1;SNX3;BBS5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.470035181278719,1.1383232403616566,0.3399602385685885,0.6740497679736649,1.0,5/22,10.29%,ATP2A3;ATP2C1;ATP6V0E2;ATP2A2;ATP6V1B2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5431140917743783,1.1358427287050608,0.31363636363636366,0.674698236765837,1.0,2/11,1.24%,MAP3K20;MAP3K5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.5206721943524465,-1.1350268919601165,0.32162661737523107,0.6947520159192551,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.5206721943524465,-1.1350268919601165,0.32162661737523107,0.6947520159192551,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,hexosyltransferase activity (GO:0016758),-0.31180744419935535,-1.1350123595987816,0.20266666666666666,0.6900078887766667,1.0,11/101,6.90%,TMTC1;EXT1;LARGE1;B4GALT1;TMTC4;CSGALNACT1;TMTC2;A4GALT;CHSY1;HEXA;HEXB
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5449224276144837,1.1325248775596168,0.33958333333333335,0.6769512601128579,1.0,3/11,14.69%,CHRNA3;CHRNA7;CHRNB2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.37372348455857113,1.132358986637532,0.27154471544715447,0.673028580808807,1.0,11/85,10.75%,NDST3;CEL;PON2;LIPC;ABHD3;PLAAT1;AOAH;MRPL58;ACHE;GDPD1;PLA2G4E
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4626364307594219,-1.131500098742905,0.3339587242026266,0.6947275714005577,1.0,1/15,1.12%,PLA2G4A
prerank,general transcription initiation factor binding (GO:0140296),-0.4080873867019007,-1.1299177217596603,0.30039525691699603,0.6945516866825094,1.0,11/25,26.26%,ESR1;TAF1;AR;AHR;RELA;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,receptor ligand activity (GO:0048018),-0.28065675096608145,-1.127520744886066,0.16589861751152074,0.6964309863210553,1.0,29/245,7.70%,BMP6;IGF1;EPHA7;WNT4;SEMA3D;BMP7;SEMA6A;TGFA;SEMA3C;IL15;WNT6;DPP4;BMP4;SEMA7A;CSF1;WNT9A;VEGFD;TNFRSF11B;VEGFC;IL16;IGF2;GAS6;FGF1;GREM2;WNT5A;CCL15;NBL1;SEMA3E;OSGIN2
prerank,protein kinase activator activity (GO:0030295),0.3946457640590284,1.1272679104744994,0.27899159663865547,0.6790849365624168,1.0,13/60,8.71%,GPRC5C;AFAP1L2;RGCC;AGAP2;NRG1;GRM5;FGF13;SPDYA;SPRY2;DDX3X;CDKN1A;STK3;MARK2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3866210258527458,-1.1272580880644678,0.28716904276985744,0.6924209490093213,1.0,17/32,36.19%,KDM7A;TET3;EGLN2;TMLHE;EGLN3;FTO;TYW5;PHYHD1;ALKBH5;TET2;EGLN1;JMJD7;TET1;HIF1AN;RIOX1;PHYH;KDM4A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3397939791218231,1.1240929791581356,0.27808988764044945,0.6812037694847078,1.0,17/173,5.07%,TBX2;HEY2;HEYL;ZEB1;PRDM1;TRPS1;ZBTB34;TBX3;ZFHX3;NR2F1;ZEB2;HESX1;NKX6-3;SCRT2;PPARD;ZBTB45;SREBF2
prerank,metal ion binding (GO:0046872),0.3078943028991567,1.12360254505711,0.22711058263971462,0.6778791857682362,1.0,80/477,11.80%,ASPN;CASQ2;MAP3K20;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;MAP3K5;RASGRP2;SNRK;CEMIP2;SLIT1;SLIT3;MARK1;ITPR2;RASGRP3;NUAK2;CIB3;EFHD2;NRXN1;PVALB;STIM2;CDC42BPA;UBA2;STK38L;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;TPPP;RYR2;ATP2A2;SIK1;CDH22;CDH19;CDH7;CDH20;AOAH;PADI2;PAPOLA;MTHFD2;STIM1;STK3;SYT1;RYR3;LETM1;MARK2;PKD2;BNIP2;HPCA;NEK6;CDH10;CDH18;DYRK3;ABL2;SPOCK1;BAIAP3;BRSK1;ASAH2;PLA2G4E;KCNIP1;RPE;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR;NLK
prerank,transition metal ion binding (GO:0046914),-0.2603899300021888,-1.1234690792166506,0.1144578313253012,0.6977819401295544,1.0,107/397,20.85%,SMAD3;LARGE1;KDM7A;B4GALT1;HDAC4;GLI2;MOXD1;AOX1;PAM;AGMO;PAPPA;EEA1;ENPP1;XPNPEP1;MYRIP;SHANK3;NPEPPS;MPPED2;SEC23A;SEC24D;NOS3;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;ATOX1;LACC1;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;PPM1M;CHD3;RNPEP;ME1;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;MGAT1;DPP3;ZMYND8;FTL;IDE;SAMHD1;MTPAP;KDM3A;DNAJC24;NSD1;GCH1;MGAT2;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;ISCA2;TYW5;SMPDL3A;PLSCR3;NOS1;TIMM13;TRIM8;SIRT2;FBXL19;PARK7;FTH1;SIRT3;ZCCHC4;ADCY2;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G;FNTB;FAM20C;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,nuclear receptor coactivator activity (GO:0030374),0.39986040802977346,1.112916943804502,0.32976827094474154,0.6952973439836827,1.0,16/52,9.60%,PKN1;NCOA7;ETS1;NCOA3;PPARGC1B;FGF2;TACC1;ACTN4;ELK1;MED13;RBM14;NCOA6;SS18;CCAR2;MED1;CNOT9
prerank,endopeptidase inhibitor activity (GO:0004866),0.37565509802773145,1.1083400009801663,0.3146067415730337,0.7001599738229528,1.0,13/82,11.21%,SERPINI1;SERPINB8;COL4A3;ROCK1;WFDC3;SERPINA10;PSMF1;BIN1;BIRC6;SPOCK3;SERPINA2;SPOCK1;PTTG1
prerank,pre-mRNA binding (GO:0036002),-0.38567380456465794,-1.1079967399369137,0.31262939958592134,0.7348113342797714,1.0,2/28,3.83%,CELF2;DDX5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.41034313482697315,-1.1075613300885858,0.34475806451612906,0.7312150323979986,1.0,5/20,20.52%,AGPAT4;LPGAT1;PLA2G15;AGPAT2;DGAT2
prerank,potassium ion antiporter activity (GO:0022821),-0.4556928490192311,-1.107066043503901,0.34026465028355385,0.7276928312302923,1.0,3/15,6.96%,SLC24A3;SLC9A2;SLC9A9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.48551892603754426,1.1044157512804438,0.3577586206896552,0.7039494674417359,1.0,7/17,15.63%,AK1;CLP1;AK8;AK7;AK5;AK3;AK4
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4511273048519605,1.1041516537601406,0.3659043659043659,0.7002586728953787,1.0,11/26,22.03%,PABIR1;PTN;PPP1R14A;PPP1R11;SET;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4331083280925808,1.1031082140432604,0.33840304182509506,0.6980240579020415,1.0,11/29,10.19%,PRKAR1B;SPRED1;PKIA;SPRY2;HEXIM1;PRKAR2B;CDKN1A;PRKAR2A;INCA1;INKA2;PRKAR1A
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.49086625534662853,-1.102848989442533,0.3541666666666667,0.7343278433312436,1.0,6/11,33.30%,NUDT4;NUDT3;NUDT16;NUDT1;NUDT5;NUDT10
prerank,DNA polymerase binding (GO:0070182),-0.4247274709460929,-1.1011211823225642,0.341747572815534,0.73434659984145,1.0,8/18,23.23%,SMG6;FANCI;CDK2AP1;HSP90AB1;NAT10;ACD;SMARCA4;RAD51
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4823649200158916,1.0994278783080076,0.36947791164658633,0.7012831917524404,1.0,7/20,13.01%,USP25;SENP5;OTUD5;DESI2;SENP1;OTUB1;USP50
prerank,kinase activity (GO:0016301),0.35281428339788706,1.0990892026499817,0.31347962382445144,0.6978706039579105,1.0,19/109,10.64%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;STK39;ITPKB;NEK1;PIK3C2A;MTOR;MAP4K4;SEPHS2;LYN;GK;COQ8A;PRKD3;NMRK1;DGKD;COASY
prerank,platelet-derived growth factor binding (GO:0048407),-0.4835008433383453,-1.0989165220162138,0.3738489871086556,0.7352384578711955,1.0,6/11,2.39%,COL1A2;COL3A1;COL1A1;PDGFRA;COL5A1;COL6A1
prerank,endopeptidase regulator activity (GO:0061135),-0.3608290122133507,-1.0981273487503913,0.31767337807606266,0.7324608610539115,1.0,6/40,11.11%,RECK;CAST;ITIH2;SERPIND1;CST3;PSME2
prerank,acetylation-dependent protein binding (GO:0140033),-0.4083673841167239,-1.0980081668208694,0.3393939393939394,0.723667662542533,1.0,6/20,9.77%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),-0.4083673841167239,-1.0980081668208694,0.3393939393939394,0.723667662542533,1.0,6/20,9.77%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.48602943130104675,1.0974053076066228,0.3697478991596639,0.6975519359903477,1.0,3/15,8.21%,CCRL2;CCR9;ACKR2
prerank,omega peptidase activity (GO:0008242),0.3686606476204244,1.0973950117711992,0.3113964686998395,0.6934893657456576,1.0,10/89,6.64%,GGT5;GGT1;USP25;JOSD2;GGH;USP40;OTUD5;UCHL1;DESI2;PAN2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4628966729395011,-1.0956863461985986,0.34470377019748655,0.7249836550140127,1.0,2/12,2.85%,AOX1;XDH
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.45881658296312017,-1.0955310931380753,0.3620689655172414,0.7209055973879468,1.0,2/14,2.95%,SLC26A7;SLC26A2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.44772410025085496,-1.0947112134220391,0.33140655105973027,0.7186052581930646,1.0,2/15,5.65%,PLA2G4A;SESTD1
prerank,anion transmembrane transporter activity (GO:0008509),-0.4702012857932415,-1.094650869695851,0.35361216730038025,0.7144486128947759,1.0,4/12,10.60%,SLCO2B1;ABCG2;SLC22A6;SLC39A8
prerank,sulfotransferase activity (GO:0008146),-0.3654288237333108,-1.0938411549316782,0.33043478260869563,0.7123047817883327,1.0,7/33,11.97%,UST;CHST11;HS3ST3A1;HS6ST1;SULT1A1;CHST15;HS3ST1
prerank,rRNA binding (GO:0019843),-0.3530675105273693,-1.091665892182787,0.30697674418604654,0.7135860492772222,1.0,18/42,25.15%,RPS14;CAVIN1;RPS13;RPS9;RPL12;RPL11;RPS5;MDM2;MRPS7;MRPS6;MRPS18A;RPL23;RPLP0;RCC1L;UTP23;FASTKD5;RRS1;RPS3
prerank,protein kinase regulator activity (GO:0019887),0.36111207965690123,1.0902569790046372,0.32057416267942584,0.7042778949015203,1.0,20/95,10.76%,GPRC5C;RGCC;SPRY4;PRKAR1B;AGAP2;FGF13;SPDYA;HEXIM1;CXCL10;PRKAR2B;SNCA;TAOK3;CDKN1A;PRKAR2A;ANKRD54;CCNC;MARK2;CCNYL1;PRKAR1A;PRKRIP1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4591296424817386,1.0900072475894205,0.35039370078740156,0.7007015644364814,1.0,1/20,0.46%,SLC30A10
prerank,nucleotidase activity (GO:0008252),-0.436879813924763,-1.0897752614256735,0.3545966228893058,0.7143972398402043,1.0,9/15,40.11%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,cation transmembrane transporter activity (GO:0008324),-0.3480123855433562,-1.0897159136080923,0.30424528301886794,0.7103206630757922,1.0,26/48,33.35%,SLC6A6;SLC41A1;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC39A1;SLC66A1;SLC7A1;SLC22A2;SLC36A1;SLC1A1;SLC38A1;MFSD12;PKD1L3;SLC6A7;SLC36A2;SLC7A3;SLC22A3;SFXN3;MMGT1;OCA2
prerank,chemorepellent activity (GO:0045499),-0.3853942769558535,-1.0887123284696825,0.35550935550935553,0.7085266026348789,1.0,6/25,3.63%,EPHA7;SEMA3D;SEMA6A;SEMA3C;DPP4;SEMA7A
prerank,protein phosphatase activator activity (GO:0072542),-0.4569530481619942,-1.0865625796307128,0.3837837837837838,0.7100108925468328,1.0,5/13,18.58%,IGFBP3;PTPA;CALM2;CALM1;PPP2R5C
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4261740069606594,1.0859467890805237,0.3269961977186312,0.7050569551457202,1.0,8/30,15.66%,SLC30A10;ATP7A;TTYH1;ATP7B;SLC31A1;SLC30A5;SLC39A6;SLC25A37
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.35467462966661184,-1.0855875633712586,0.3287981859410431,0.7083629866230209,1.0,12/44,19.82%,MECOM;SMYD3;SETD7;SETD1B;KMT5A;PRDM16;EHMT1;NSD1;KMT5C;EZH2;SMYD5;SETDB1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3933493934900203,-1.0854840634917846,0.34243697478991597,0.7045450715902312,1.0,8/24,17.93%,RPS14;RPL41;RPS13;IGF2BP2;MYH10;RPL26;LARP1;RPS7
prerank,hyaluronic acid binding (GO:0005540),-0.48040402617806877,-1.085280850042864,0.3764705882352941,0.7009541948614061,1.0,4/10,25.35%,CEMIP;LAYN;LYVE1;CD44
prerank,nucleotidyltransferase activity (GO:0016779),-0.41794010736091697,-1.0823073530693224,0.3782696177062374,0.7042603151571427,1.0,7/19,20.22%,REV1;PAPSS2;TUT4;TUT7;MTPAP;PNPT1;TENT4B
prerank,ligand-gated anion channel activity (GO:0099095),0.4713807252705369,1.076653686149741,0.37777777777777777,0.719761693427608,1.0,7/17,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GLRB;GABRB2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4795833445752808,1.0764413316520955,0.3752620545073375,0.7161421400575732,1.0,3/15,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,kinase activator activity (GO:0019209),0.4243033445166898,1.076181476960761,0.3687258687258687,0.7126977805179117,1.0,5/30,4.45%,GPRC5C;RGCC;AGAP2;FGF13;SPDYA
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4921212284793475,1.0761675475533383,0.385395537525355,0.7087419349669402,1.0,3/14,9.84%,NCF2;NCF1;NOX3
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4591257887802108,-1.0754520243286603,0.3717948717948718,0.7171055683010779,1.0,3/13,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,myosin II binding (GO:0045159),-0.4785737940242272,-1.0748346362654275,0.3719626168224299,0.7146131946708378,1.0,4/10,14.92%,GSN;SHROOM4;TRIOBP;LLGL2
prerank,calcium-release channel activity (GO:0015278),0.4668867433485629,1.0729378437961736,0.38767395626242546,0.711045067678254,1.0,6/17,12.93%,ITPR2;ITPR1;RYR2;RYR3;PKD2;RASA3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.46735380274067273,-1.0727172210971134,0.40217391304347827,0.7158315880212702,1.0,3/12,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,acetylcholine receptor activity (GO:0015464),0.4580845050098218,1.0710468064064969,0.3795180722891566,0.7108452268306186,1.0,6/22,18.01%,CHRNA3;CHRNA7;CHRFAM7A;CHRNB2;CHRM3;CHRM2
prerank,semaphorin receptor binding (GO:0030215),0.44341474071084114,1.0706515513373114,0.3661417322834646,0.7077478922725037,1.0,6/23,4.92%,SEMA6D;SEMA5A;PLXNB1;SH3BP1;SEMA6C;RIT2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.43472752226779643,-1.0666323612247164,0.38846153846153847,0.7269376851890115,1.0,3/15,10.60%,SLC26A7;SLC26A2;SLC39A8
prerank,protein phosphatase binding (GO:0019903),0.3367639037552262,1.0663328888204526,0.3621212121212121,0.7125679424161704,1.0,16/117,10.22%,ITGA1;SMTNL2;MAP3K5;PTK2;PIK3R1;AKAP11;ADCY8;MYO16;JAK1;ROS1;ANKLE2;TRAF3;PTPRT;PPP1R16A;STRN;KIF3A
prerank,calcium:sodium antiporter activity (GO:0005432),-0.48152181049226983,-1.0646957505756862,0.4035714285714286,0.7278084585841393,1.0,3/10,11.28%,SLC24A3;SLC8A3;SLC3A2
prerank,cardiolipin binding (GO:1901612),-0.4797935042844205,-1.0636812068039943,0.4293785310734463,0.7261440725896442,1.0,4/10,30.55%,GSDME;GSDMD;PLEKHN1;STOML2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.49031003152240504,1.0631585907234968,0.37684210526315787,0.7153557632312865,1.0,5/13,17.93%,GABRG2;GABRA2;GABRA5;GABRA4;GLRB
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.44559885377541664,1.0624320257194826,0.396078431372549,0.7129510140299745,1.0,7/21,10.00%,WASF3;AKAP1;AKAP6;ARFGEF1;RYR2;WASF2;AKAP7
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.467594587999473,1.059421610590763,0.4080338266384778,0.7152286518081061,1.0,3/16,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3972427455772306,-1.0590212612303194,0.3788187372708758,0.7335652296053305,1.0,9/21,29.84%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,DNA polymerase activity (GO:0034061),-0.39375102866746386,-1.0562922314374221,0.3860369609856263,0.7366279772340323,1.0,9/22,29.84%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,ferrous iron binding (GO:0008198),-0.3965155353314821,-1.0539267801391958,0.41333333333333333,0.73844114673459,1.0,14/21,38.48%,EGLN2;EGLN3;FTL;DNAJC24;FTO;FTH1;TET2;EGLN1;CDO1;HIF1AN;ACP5;HAAO;PHYH;HEPH
prerank,TBP-class protein binding (GO:0017025),-0.39480138413245636,-1.048439419790997,0.4227005870841487,0.7481851824676933,1.0,9/21,26.26%,ESR1;TAF1;AHR;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4484105364518156,-1.047224134088633,0.4198198198198198,0.7473678313607509,1.0,3/12,11.09%,PIEZO2;PIEZO1;TMC6
prerank,estrogen receptor binding (GO:0030331),0.4109684190085986,1.0470715035906082,0.3678373382624769,0.735766962259882,1.0,8/32,10.15%,RERG;PPARGC1B;TACC1;ARID5A;PADI2;NCOA6;MED1;STRN
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4435691981515972,1.045935616978123,0.38675213675213677,0.7341102512646421,1.0,4/18,10.26%,PIK3R1;AGAP2;SOCS5;SOCS6
prerank,ephrin receptor binding (GO:0046875),0.44192703674966727,1.0458756676876766,0.3946869070208729,0.7303267892535888,1.0,5/21,13.17%,CHN1;ANKS1B;LYN;SRC;PTPN1
prerank,SUMO binding (GO:0032183),0.47783672879586503,1.0457723169481525,0.41702127659574467,0.726613548260095,1.0,2/13,3.78%,USP25;UBA2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.26427287067096755,-1.0448279314962956,0.30685920577617326,0.7495079668590027,1.0,40/181,15.40%,SMAD3;HDAC4;MDFIC;ANXA4;KLF4;TACC2;TCF7L2;NFATC1;TAF1;ZFPM2;PARP9;ARNT2;WWP2;AR;PRRX1;RERE;GTF2I;BHLHE40;ATN1;MAPK14;LMO2;STAT1;STAT3;IFI27;FIZ1;DTX3L;BBS7;HIF1A;BHLHE41;HDAC1;RELA;PPARA;ID2;MEF2A;HDAC5;TAL1;ACTB;HIPK2;TAF4B;ZFPM1
prerank,neurexin family protein binding (GO:0042043),0.5071400237702809,1.0443179232332644,0.40130151843817785,0.7258468649440369,1.0,1/10,0.67%,CEL
prerank,protein phosphatase 1 binding (GO:0008157),0.442072870745832,1.0432432118049313,0.40993788819875776,0.7241921602548509,1.0,2/21,2.09%,SMTNL2;AKAP11
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2612653851840245,-1.0419594978002948,0.35231316725978645,0.7527532629943611,1.0,41/189,13.79%,SMAD3;HDAC4;FHL2;HDAC7;KLF4;TCF7L2;TLE4;NFATC1;TAF1;HDAC9;SKI;ZFPM2;WWP2;AR;CREM;YAP1;PRRX1;RERE;GTF2I;BHLHE40;ATN1;PRDM16;LMO2;STAT1;STAT3;IFI27;FIZ1;BBS7;TLE2;ZMYND8;TLE1;BHLHE41;PRDM5;HDAC1;RELA;PPARA;ID2;MEF2A;USF1;HDAC5;TAL1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4419346441099566,-1.0403447131552106,0.43399638336347196,0.753080367431215,1.0,7/12,38.24%,KDM7A;KDM3A;HR;KDM1A;JMJD1C;KDM4A;PHF2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4959791015615811,1.0378391523102302,0.4201312910284464,0.7310376826389595,1.0,2/11,3.41%,SLC19A1;SLC25A25
prerank,protein serine/threonine kinase activity (GO:0004674),0.29663017456645585,1.036492953750452,0.40253164556962023,0.7298116852455444,1.0,59/334,11.50%,MAST4;MAP3K20;KALRN;CDK6;MAP3K5;MYLK;SNRK;PKN1;MARK1;HUNK;NUAK2;ROCK1;AKT3;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;SRPK3;RPS6KB2;MINK1;CSNK1G1;RPS6KA2;TESK2;MYLK4;TESK1;TTBK1;TAOK3;SIK1;PAK6;PIKFYVE;RIPK2;STK3;STK24;MTOR;ALPK1;GRK5;ACVR2B;MARK2;MAP4K4;PRKD2;CSNK1E;MAP4K1;PAK5;PRKD3;PDIK1L;MAPK10;NEK6;ATR;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4208560695361515,1.0315685026548944,0.4087301587301587,0.7359107270508629,1.0,10/23,18.11%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPU;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,translation elongation factor activity (GO:0003746),-0.4202572662893952,-1.0301320046348763,0.45506692160611856,0.7756258153385629,1.0,5/14,16.81%,EEF1A1;EIF5A;EIF5AL1;EEF1B2;EEFSEC
prerank,sodium channel regulator activity (GO:0017080),0.3989890427458323,1.0300299461594975,0.42095914742451157,0.7354768439063343,1.0,9/37,11.63%,NEDD4L;FGF12;FXYD2;FGF13;PRSS8;SCN2B;RANGRF;FGF11;FGF14
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4914249802973904,1.0280932988512723,0.43080357142857145,0.7356877282557618,1.0,2/11,3.19%,PABIR1;PPP1R14A
prerank,protein kinase inhibitor activity (GO:0004860),0.3828765131864122,1.027488348019931,0.42678571428571427,0.7333722452013466,1.0,9/42,10.76%,SPRY4;SPRED1;SPRY2;HEXIM1;SNCA;TAOK3;CDKN1A;INKA2;PRKRIP1
prerank,ankyrin binding (GO:0030506),0.4314437499627519,1.0254238722234077,0.4394904458598726,0.7336444513616327,1.0,5/19,7.39%,SPTBN1;SPTB;SCN5A;KCTD6;CACNA1D
prerank,RNA binding (GO:0003723),-0.2167883672889277,-1.023941323164718,0.375,0.7867871484586753,1.0,397/1321,26.57%,CELF2;MSI2;SAMD4A;DCN;ROCK2;BICC1;AHNAK;NSA2;FNDC3B;RBFOX2;HOXB6;STRBP;MACF1;VIM;RBMS2;DIAPH1;MBNL1;ANXA2;MYO18A;GOLGB1;LBR;ASCC3;EZR;CAST;PLEC;RPS14;CMSS1;LARP4B;DDX5;RBM47;DDX60;RBM20;RPL9;TUT4;MOV10;SERPINH1;RPS12;THRAP3;TUT7;LUC7L;EDC3;P4HB;RPL41;SRRM2;RPS20;CAVIN1;SIDT1;NUDT4;HDLBP;TES;DDX6;SSBP1;CHD3;NYNRIN;RPL18A;RARS2;STAT3;AFF2;RPS13;RPS19;CPEB2;RPS23;SRBD1;RPS4X;CCDC9;LARP1B;TFRC;TEP1;NOCT;SIDT2;ZYX;TMSB4X;IFIT2;RPS11;RTF1;IGF2BP2;ARHGEF1;POLR2A;EIF4A1;TPT1;UTP14A;RPL13;RC3H2;NOVA2;ACO1;MKRN2;SMG6;MYH10;SON;RPL18;ZFR2;FAM120A;SORBS2;COL14A1;RPS9;EIF2S2;EEF1A1;DENR;RPL34;RPL32;REXO4;OAS2;NAF1;PINX1;PCBP2;KRR1;RBM33;VIRMA;UTP11;CTNNA1;RPL27A;RPS8;IFIT3;RPL12;ATXN2;IFIT1;FAM120C;RPL37;SAMHD1;KARS1;USO1;ZC3H12A;RBM10;FKBP4;DHX32;EIF5A;ANXA7;MTPAP;NXF1;NDUFV3;TDRD3;NOP58;SLC3A2;RPL11;RPS18;RBM42;ANXA11;PUM1;ERI3;EIF4G3;ADD1;TRIP6;PFN1;SUCLG1;CKAP4;CARS1;RPL39;RPS5;RPS16;STRAP;RPL24;NME1;LRRFIP1;RPS15A;HELZ;ELP1;UTP6;MBNL2;CPEB3;ISG20L2;ACTN1;GRSF1;CHD2;TCOF1;TENT5A;NOVA1;YBX3;RPL28;SRSF10;FNDC3A;RPS24;RAN;SF3B6;CALR;RPS27;RPL14;DDX49;RPL26;FAU;LARP1;LRRC47;MRPS7;TXN;EIF4A2;CS;SARS1;TUBA1B;RAMAC;RPL10;GEMIN5;PPIA;BYSL;ENO1;RPL7;HSP90AB1;SNIP1;MRPS24;DDX24;SLTM;PRPF3;MAZ;FXR2;SCG3;CHCHD1;EIF5B;RPL10A;AGFG1;ZCCHC17;NUP98;RPL22;RBM34;RPS15;RPS6;XPOT;SPATS2L;RPL23;RPL17;TYW5;GANAB;PDIA3;SNRPF;SEC23IP;G3BP1;MRPL15;XRN1;NKRF;CEBPZ;SLIRP;HMGB2;EBNA1BP2;ELAVL1;RPL31;PPHLN1;PNPT1;RNASEL;TRMT2A;TRNAU1AP;TRMT10B;TNRC6A;SRSF2;SNRPD1;SNRPD2;SMG5;ELAC2;HNRNPUL2;HNRNPAB;RPS25;NOL12;SNRNP40;PSIP1;TOE1;TPR;RPL15;RPSA;PNLDC1;LSM5;DYNC1H1;RPS7;SRSF6;RRP8;KCTD12;PARK7;PSMD4;EIF4E2;RPL38;MRPL39;RPLP0;HSP90B1;RPL27;CSDC2;PTBP3;ZFP36L2;HMGN5;EIF1B;AGO1;PPARGC1A;UNC50;VCP;PABPC4L;NAT10;LGALS1;CANX;TEFM;SF3B5;TFB1M;ESF1;RCC1L;POLRMT;PNO1;RRBP1;NONO;SMC1A;UBTF;ERH;TENT4B;RPL36A;DDX55;DICER1;DRG2;RRP12;FARSA;USP36;ZC3H18;HNRNPL;CCDC86;SRPK1;RPP38;SAMSN1;MRPL12;MRPL1;PURG;RRP7A;PCBP4;FTSJ3;TCF20;RBBP6;SEC61B;SRF;NELFCD;RPS26;DZIP3;UTP23;ASS1;TOP2A;RPS27L;LRRC59;SRSF5;WRAP53;NUDT16;TUBB4B;LYAR;HSPA9;RPL35A;ALDOA;WBP11;MRPS26;DHX34;FIP1L1;DSP;TRUB2;CSDE1;DNAJC21;HELZ2;EXOSC7;SAMD4B;APEH;DHX8;RDX;CCDC47;SF3A3;BRCA1;RPL8;USP10;YWHAE;RPL36;MTHFSD;EIF3B;POLR2G;CDK11B;ALKBH5;CELF5;FASTKD5;ZNF326;MEX3A;LSM7;SRSF11;RRS1;SRPK2;RPS3;PEG10;ZBP1;S100A16;DNAJC2;ACIN1;MRPL4;HNRNPF;RACK1;HNRNPA0;ZNF106;CPNE3;NUDT1;RPL13A;ZC3H12B;FBL;POP1;NHP2;MRPL21;EIF2AK4;ABCF1;MRPL54;PUF60;G3BP2;RPUSD4;DDX54;CLK3;RBMX2;PEBP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3588096244742178,-1.0207197884871642,0.42650103519668736,0.7909179040516242,1.0,8/28,15.77%,LRRK2;MAP2K6;MAPK14;MAP2K5;AKT1;PRKCG;MAPKAPK3;PRKAA2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3975519230822035,1.020642034685035,0.4293785310734463,0.7395375452700227,1.0,8/35,12.53%,PTK2;PEAK1;FRK;CSK;LYN;ABL2;TEC;SRC
prerank,SUMO transferase activity (GO:0019789),-0.405419031474892,-1.0198216243381144,0.40892193308550184,0.789001380316051,1.0,5/16,24.62%,HDAC4;MDM2;CBX4;PIAS4;PIAS3
prerank,protein heterodimerization activity (GO:0046982),-0.25746447765452785,-1.016293114975551,0.4013605442176871,0.7939085229175995,1.0,60/178,25.85%,BMP6;EXT1;TCF4;TAF1;ITGA3;ZHX3;SDCBP;IRAK2;ARNT2;HEXA;BHLHE40;P4HB;BDKRB2;TOP2B;FZD4;ADRA1B;MCL1;HIF1A;KCNB1;NR4A2;ATF6;BHLHE41;IRAK3;ADD1;AHR;TCOF1;MEF2A;USF1;SAE1;RAN;CYBA;ATP1A1;RALGAPA2;FXR2;VAPA;UBA3;MICU2;SMC3;TLR4;USF2;LSM5;AGTR1;MICU1;IKBKG;YWHAH;SMC1A;CYBB;XBP1;TOP2A;SNX2;PAFAH1B1;ABCG4;TRMT112;YWHAE;MIGA1;BCL2L1;ATF3;RRAGC;NR4A1;TP53
prerank,actinin binding (GO:0042805),0.4334980696025335,1.0153787222943405,0.4227467811158798,0.7458708824652859,1.0,1/21,0.34%,CACNA1C
prerank,O-acyltransferase activity (GO:0008374),0.4081547237629856,1.0138609801762766,0.4530386740331492,0.7451307659109789,1.0,3/30,7.19%,MBOAT2;MBOAT4;PLAAT1
prerank,PDZ domain binding (GO:0030165),-0.3065523005523431,-1.0138053923277586,0.4200477326968974,0.79610651310428,1.0,18/61,12.75%,TGFBR3;DOCK4;CXADR;FZD2;SNTG2;ARHGAP29;SYNJ2;SLC22A4;USHBP1;ERC1;FZD4;ACOX1;FZD7;SLC22A5;TBC1D10A;F11R;CLCN3;CCDC88C
prerank,tau protein binding (GO:0048156),0.3838389834334813,1.0123374762800401,0.41952983725135623,0.7443414935968468,1.0,18/40,22.59%,MAP2;MARK1;ROCK1;TTBK1;SNCA;BIN1;MARK2;BRSK1;EP300;DCTN1;PRKAA1;CDK5;GSK3B;MARK4;STUB1;PPP2CB;PICALM;LGMN
prerank,zinc ion binding (GO:0008270),-0.24046508583935358,-1.0103179713992674,0.3964757709251101,0.8011053816452183,1.0,82/293,20.85%,SMAD3;KDM7A;HDAC4;GLI2;PAM;PAPPA;EEA1;ENPP1;MYRIP;SHANK3;NPEPPS;SEC23A;SEC24D;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;CHD3;RNPEP;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;DPP3;ZMYND8;IDE;SAMHD1;DNAJC24;NSD1;GCH1;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;SMPDL3A;TIMM13;TRIM8;SIRT2;FBXL19;SIRT3;ZCCHC4;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G;FNTB;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4739099905463039,1.006886480619874,0.4264069264069264,0.7508104942145595,1.0,2/12,3.41%,SLC19A1;SLC25A25
prerank,cytokine receptor binding (GO:0005126),-0.28273220522496323,-1.0043590289781636,0.4572192513368984,0.8121125377319767,1.0,16/83,12.04%,TGFBR3;SMAD3;IL6R;IL6ST;CSF1;SOCS2;VEGFD;SDCBP;VEGFC;CXCL12;FKBP1A;ERAP1;USP15;IL18;TRIP6;CCL25
prerank,retinoic acid binding (GO:0001972),-0.4332089757355821,-1.0043420958877431,0.478494623655914,0.8080329705983395,1.0,3/12,26.11%,CYP26B1;RARA;RXRA
prerank,poly(U) RNA binding (GO:0008266),0.41848258759420226,1.0018114105794185,0.44123711340206184,0.7572673423190782,1.0,9/20,18.11%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,double-stranded RNA binding (GO:0003725),-0.2891320606294576,-1.0014075974215495,0.46633416458852867,0.8118464644241244,1.0,16/70,14.30%,STRBP;VIM;MBNL1;DDX60;SIDT1;TFRC;SIDT2;EIF4A1;RC3H2;ZFR2;OAS2;SLC3A2;LRRFIP1;ACTN1;TUBA1B;HSP90AB1
prerank,thyroid hormone receptor binding (GO:0046966),0.39771149277677176,0.9983425498587836,0.45590994371482174,0.7604423636795883,1.0,10/28,18.03%,NCOA3;TACC1;MED13;ARID5A;NCOA6;MED1;MED4;GTF2H1;HMGN3;MED30
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.39562309854446137,0.9981787264960086,0.4453125,0.7570324458511241,1.0,5/29,5.46%,SLC1A5;SLC1A4;SLC19A1;SLC26A1;SLC25A13
prerank,GTP binding (GO:0005525),0.3009871995541029,0.9979679654258872,0.4488078541374474,0.7536784404666412,1.0,17/172,8.87%,RASL12;REM1;RERG;RND3;AGAP2;RRAD;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,tau-protein kinase activity (GO:0050321),0.4398539569894014,0.9959863315590116,0.4578313253012048,0.7536068030337075,1.0,9/20,18.48%,MARK1;ROCK1;TTBK1;MARK2;BRSK1;PRKAA1;CDK5;GSK3B;MARK4
prerank,kinase binding (GO:0019900),0.27820670575911916,0.9955907028332738,0.4880382775119617,0.7507653147527151,1.0,37/434,6.89%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;IL15RA;PTK2;RGCC;BCAR1;TNS2;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;ATP1A4;PTPN22;DOK7;ABI2;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;SCN5A;TNIP2;SYN1;SIK1;KIZ;CASP9;YWHAZ;EMP2
prerank,androgen receptor binding (GO:0050681),-0.360601390209514,-0.9943986648560234,0.46987951807228917,0.8249392662320159,1.0,7/25,13.04%,FOXP1;DDX5;TMF1;PRKCB;KDM3A;NSD1;CALR
prerank,galactosyltransferase activity (GO:0008378),-0.43665542807242136,-0.9941986108486213,0.49063670411985016,0.8213155650124274,1.0,2/11,5.00%,B4GALT1;A4GALT
prerank,ATPase activator activity (GO:0001671),-0.3836820736710329,-0.9933653335191285,0.469061876247505,0.819349365815717,1.0,7/20,18.31%,ATP1B3;TOR1AIP1;DNAJB2;DNAJC24;DNAJB6;DNAJC15;DNAJC10
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4562043811576085,0.9930926247028704,0.43333333333333335,0.7517586481200211,1.0,5/12,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;TRIM37
prerank,microtubule binding (GO:0008017),0.2925553959440918,0.991233355145852,0.46530612244897956,0.75166558437571,1.0,32/222,11.89%,SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;SVBP;FGF13;NAV3;GAS8;CLASP2;MAPRE2;TPPP;STIM1;KIF26B;HOOK3;FAM161A;MAP4K4;CLIP2;NUSAP1;KIF3A;UXT;CAMSAP3;TOGARAM2;MACO1;TPGS1;CCDC66;KIF20A;KIF5C;APC;KIF3C
prerank,protein kinase binding (GO:0019901),0.27612690492955283,0.9889115769050099,0.48991696322657174,0.7526318452877994,1.0,52/479,8.76%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;PRKCSH;IL15RA;PTK2;RGCC;PKN1;BCAR1;PRKAR1B;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;DOK7;SH2B3;PKIA;GRM5;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;TRIB2;SCN5A;ITGB1;TNIP2;SYN1;PRKAR2B;RYR2;SIK1;APPL1;KIZ;CASP9;YWHAZ;EMP2;IRS1;CDKN1A;PPP1CC;PRKAR2A;GRK5;SHC4;RAB11FIP2;CSK
prerank,retinoic acid receptor binding (GO:0042974),0.43934036897308193,0.9879753260419818,0.4581589958158996,0.7509687313320641,1.0,7/17,17.07%,TACC1;ACTN4;ARID5A;NCOA6;MED1;CNOT1;NRIP1
prerank,histone deacetylase binding (GO:0042826),0.33333736886781407,0.9871021196886968,0.47217806041335453,0.7491212242253317,1.0,5/88,3.99%,MEF2C;HEY2;PRDM1;PKN1;MIER1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.43718137708937543,-0.9869725304441584,0.49364791288566245,0.8315996710233879,1.0,6/10,31.35%,BRCA2;NAA40;USP22;HAT1;ATF2;NAA60
prerank,nuclear export signal receptor activity (GO:0005049),-0.44065659730019435,-0.9865758976518,0.48417132216014896,0.8284487378273284,1.0,7/11,30.30%,RAN;NUP214;XPO4;RANBP17;EIF4ENIF1;CSE1L;XPO5
prerank,antiporter activity (GO:0015297),-0.37459153030037257,-0.9865469800296502,0.4894837476099426,0.8244549275691493,1.0,5/20,16.02%,TMEM241;CLCN3;ATP1A3;SLC35D2;SLC35E4
prerank,E-box binding (GO:0070888),0.38273470291378087,0.9858086515878374,0.45765765765765765,0.748281512547848,1.0,6/34,11.06%,ZEB1;TCF15;SCRT2;SREBF2;MITF;SNAI2
prerank,protein kinase C binding (GO:0005080),-0.3152866073228667,-0.9857113135270456,0.47045454545454546,0.8224911992408653,1.0,12/43,13.94%,PDLIM5;HDAC7;CAVIN2;ADAM9;HDAC9;PARD6G;PRKCB;TOP2B;HINT1;TRPV4;HDAC5;CAVIN3
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.37632177819502344,-0.9850667205063268,0.4819047619047619,0.8200703732788123,1.0,4/20,7.97%,TJP2;DLG1;MAGI3;CMPK1
prerank,heme binding (GO:0020037),0.3447689775888175,0.9841777617547001,0.4614065180102916,0.7480614385658614,1.0,1/65,0.12%,GUCY1B1
prerank,magnesium ion binding (GO:0000287),0.30956900049705643,0.9782566861673503,0.4611801242236025,0.756032610631668,1.0,22/135,11.80%,MAP3K20;MAP3K5;SNRK;MARK1;NUAK2;CIB3;CDC42BPA;UBA2;STK38L;SNCA;TPPP;SIK1;PAPOLA;MTHFD2;STK3;MARK2;NEK6;DYRK3;ABL2;BRSK1;SRR;NLK
prerank,amyloid-beta binding (GO:0001540),0.33022629091421796,0.9775033245139153,0.4851657940663176,0.7541347128663812,1.0,13/79,10.24%,CLSTN1;APBB2;FZD6;LDLRAP1;LDLR;MSR1;GRIA2;CHRNA7;ACHE;ITM2B;GRIN2B;CACNA1A;APBA2
prerank,alpha-actinin binding (GO:0051393),0.40546291237549675,0.9763251331441051,0.4688128772635815,0.7530790494614805,1.0,4/24,9.03%,CACNA1C;PDLIM1;CACNA1D;PKD2
prerank,cell adhesion mediator activity (GO:0098631),0.4018582702512052,0.9761610817151222,0.4881422924901186,0.7499109523044605,1.0,7/24,13.51%,JAM3;LRRC4C;ESAM;CNTN4;CNTN6;PLXNB3;DSCAM
prerank,potassium:proton antiporter activity (GO:0015386),-0.4449269097088564,-0.9754617575529364,0.5288808664259927,0.8403470101304702,1.0,3/10,17.51%,SLC9A2;SLC9A9;SLC9A1
prerank,cytokine activity (GO:0005125),-0.25736934262967504,-0.9713921884480482,0.5331325301204819,0.8457132156178545,1.0,19/131,12.10%,BMP6;WNT4;BMP7;IL15;WNT6;BMP4;CSF1;WNT9A;TNFRSF11B;IL16;CXCL12;WNT5A;CCL15;CCL14;IL33;IL18;TGFB1;CCL25;WNT5B
prerank,protein phosphatase 2A binding (GO:0051721),-0.3563857788584297,-0.9658568502012151,0.521484375,0.8556355595253041,1.0,7/23,16.95%,FOXO1;CTTNBP2NL;MFHAS1;PTPA;DAB2IP;SPHK1;SMG5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4539948685750264,0.9653985046589536,0.5107758620689655,0.7665879142879108,1.0,2/12,6.79%,ATP2A3;BCL2L13
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.32564204009383124,-0.9644900578064308,0.5508849557522124,0.8549563194716496,1.0,8/34,16.18%,IQGAP1;IGF2;CALM2;ALS2;IRGM;DBF4;PARP16;CALM1
prerank,small GTPase binding (GO:0031267),0.28849449502408264,0.9640548630769346,0.5064011379800853,0.7657259816555889,1.0,29/169,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,peptidoglycan binding (GO:0042834),-0.44130316503883993,-0.9638983765826147,0.5223048327137546,0.8522290503553361,1.0,2/10,9.38%,NOD1;PGLYRP1
prerank,methylated histone binding (GO:0035064),-0.2902995686938643,-0.9630869593191983,0.5102974828375286,0.8501643262235477,1.0,22/62,28.16%,KDM7A;TAF1;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;CHD5;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3
prerank,methylation-dependent protein binding (GO:0140034),-0.2966380657672249,-0.9627990730171918,0.5265588914549654,0.8469850343366347,1.0,29/57,38.25%,KDM7A;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3;RBBP5;JMJD7;CBX8;ATRX;UHRF1;KDM4A;KMT2E;PHF2;PHF1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.43689632349358254,0.9626759511956906,0.4875,0.7651617118601579,1.0,2/14,6.79%,ATP2A3;BCL2L13
prerank,mRNA binding (GO:0003729),-0.22999617793647092,-0.9589858677110361,0.5909090909090909,0.852169766659858,1.0,60/249,19.27%,CELF2;SAMD4A;RBFOX2;RBMS2;RPS14;LARP4B;DDX5;RBM47;RBM20;LUC7L;EDC3;RPL41;SRRM2;HDLBP;DDX6;NYNRIN;RPS13;CPEB2;SRBD1;NOCT;IGF2BP2;EIF4A1;RC3H2;NOVA2;ACO1;MYH10;EIF2S2;DENR;PCBP2;ZC3H12A;PUM1;EIF4G3;RPS5;CPEB3;GRSF1;NOVA1;YBX3;SF3B6;CALR;RPL26;LARP1;MRPS7;AUH;GEMIN5;RPL7;SNIP1;FXR2;NUP98;G3BP1;ELAVL1;RNF40;HNRNPAB;TPR;RPS7;SRSF6;PARK7;TYMS;CSDC2;PTBP3;PABPC4L
prerank,5'-3' exonuclease activity (GO:0008409),0.4281331494864049,0.9582533599056829,0.4894957983193277,0.7698064563870786,1.0,3/14,10.41%,DCLRE1B;XRN2;TRIR
prerank,chemokine activity (GO:0008009),-0.3237082582614419,-0.9537269389173941,0.5170212765957447,0.8611817757755865,1.0,19/31,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;CX3CL1;CCL28;CCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,death receptor binding (GO:0005123),-0.38368244009067776,-0.9533967845010444,0.5304518664047151,0.8580542299290294,1.0,9/15,39.47%,DAB2IP;BID;RIPK1;EDA;NTF3;MYD88;FADD;PIDD1;CASP8AP2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3393046784215187,-0.9522346343396358,0.5117773019271948,0.857079543964219,1.0,11/27,25.65%,RNF19A;RNF144B;RNF125;PPARA;ANKIB1;UBE3D;RNF217;RNF144A;RNF19B;FOXL2;PRKN
prerank,DNA secondary structure binding (GO:0000217),0.3785473898579652,0.951054497102551,0.517578125,0.7804570534904334,1.0,1/31,0.63%,MEF2C
prerank,gated channel activity (GO:0022836),-0.3894227267388242,-0.9472549406865671,0.5387453874538746,0.8647306256998027,1.0,3/14,11.09%,PIEZO2;PIEZO1;TMC6
prerank,clathrin adaptor activity (GO:0035615),-0.3904218127048218,-0.9466127397753913,0.5333333333333333,0.8623425013925867,1.0,3/15,5.05%,DAB2;STON2;AP2A2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4217437605801309,0.946373691122793,0.5031982942430704,0.7858386457485653,1.0,5/13,13.50%,TRMT5;TRMT1;THUMPD2;TRMT11;TRMT10C
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4224444866604865,0.9453377342437221,0.5032822757111597,0.7843705663907937,1.0,5/14,15.63%,AK1;AK8;AK7;AK5;AK4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3232581737828686,-0.943200700667597,0.5329087048832272,0.8666831893263341,1.0,13/32,24.22%,SLC6A6;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC43A1;SLC36A1;SLC1A1;SLC38A1;MFSD12
prerank,calcium channel inhibitor activity (GO:0019855),-0.41198616303729974,-0.9422181716715109,0.544256120527307,0.8652003028017629,1.0,5/11,17.40%,CALM2;FKBP1A;MCUB;CALM1;SLC30A1
prerank,acetyltransferase activity (GO:0016407),-0.324131070971438,-0.9417453181778137,0.5790598290598291,0.8624812572241334,1.0,8/31,21.28%,KAT6B;KAT2B;SPHK1;PAFAH2;ELP3;NAT10;SAT1;NAA80
prerank,hexose transmembrane transporter activity (GO:0015149),0.4347158277276164,0.9390964516901734,0.5248756218905473,0.7927779133297147,1.0,3/12,8.29%,SLC5A1;SLC2A6;SLC2A3
prerank,GABA receptor activity (GO:0016917),0.39999391162976466,0.9383268668405778,0.5196850393700787,0.7907941131212939,1.0,7/21,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABBR2;GABRB2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4024386424079683,0.9367229645526628,0.5118790496760259,0.7903323204364112,1.0,1/18,1.67%,RDH5
prerank,calcium-activated potassium channel activity (GO:0015269),0.45334559059902446,0.936657876687518,0.4978723404255319,0.7870426820690767,1.0,3/11,14.13%,KCNMB1;KCNMA1;KCNU1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.45146501310585047,0.9364479270677829,0.5032822757111597,0.7839904164916396,1.0,4/11,12.93%,ITPR1;RYR2;RYR3;RASA3
prerank,U6 snRNA binding (GO:0017070),0.4212135021075431,0.9355687622362551,0.48590021691973967,0.7822456970887934,1.0,5/14,17.68%,LSM3;SART3;LSM8;LSM2;LARP7
prerank,protein homodimerization activity (GO:0042803),0.25444112083946574,0.935459554634913,0.6489241223103058,0.7791099941547452,1.0,66/589,10.39%,ANO1;TRPC6;CASQ2;IMPA2;PTH1R;FAP;RBPMS;MAP3K5;SYNE1;RBPMS2;MTCL1;RDH5;TRIM9;MYH9;DCLRE1B;ERBB4;PLD6;PIP4K2A;ECE1;MID2;ABCD2;BCL2L10;GUCY2D;ADCY8;PDCD10;CRPPA;PEX7;CARD9;ACTN4;TFAP2B;NTRK2;TPPP;SFPQ;CHRNA7;APPL1;PSMF1;RCHY1;SUPV3L1;PADI2;RIPK2;TYR;PTPRT;HMGCS1;ACHE;DCK;STC2;TENM4;CORO1A;RAB11FIP2;ARNT;CIP2A;PKD2;NR2F2;MSH3;PDGFB;ZDHHC2;TARBP2;CR2;CNOT9;MYOM1;EFEMP2;GNPTG;DARS2;HIP1;TBX18;DGKD
prerank,chloride transmembrane transporter activity (GO:0015108),-0.37152489477700107,-0.9346897714974065,0.5506692160611855,0.8752101998658488,1.0,2/16,2.95%,SLC26A7;SLC26A2
prerank,mannose binding (GO:0005537),-0.39926835344718625,-0.9318644044391544,0.5720081135902637,0.8779044696166692,1.0,6/12,46.36%,LMAN1;CLN5;ACR;COLEC11;LMAN1L;CLEC4D
prerank,microtubule plus-end binding (GO:0051010),0.39048193459546315,0.9316732041099367,0.5372233400402414,0.7827861061346647,1.0,9/20,18.78%,CLASP2;MAPRE2;STIM1;CLIP2;APC;DCTN1;CLIP1;DST;KNSTRN
prerank,glutamate receptor binding (GO:0035254),-0.36758592639174975,-0.9294502990389473,0.574757281553398,0.8793653705249277,1.0,6/17,17.12%,SHANK3;GNAS;CAMK2A;SHISA7;HOMER1;HOMER3
prerank,ubiquitin protein ligase activity (GO:0061630),-0.22944038751014365,-0.9290239830387982,0.6865079365079365,0.8765431006558135,1.0,49/228,16.97%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;UBE4B;RNF125;MDM2;TRIM63;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.36348144376522823,-0.9283235213284041,0.562962962962963,0.8704500938956031,1.0,5/16,15.25%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.36348144376522823,-0.9283235213284041,0.562962962962963,0.8704500938956031,1.0,5/16,15.25%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3318137758273201,0.9263481266892102,0.5355285961871751,0.7893157195528919,1.0,4/57,5.41%,COX4I2;NDUFA4L2;UQCRFS1;NDUFB2
prerank,snRNA binding (GO:0017069),0.35193193541817824,0.9247892188570227,0.5149253731343284,0.788741413267718,1.0,13/42,17.68%,HEXIM1;NCBP2;LSM10;SART3;RBM7;HNRNPU;LSM8;COIL;PRPF31;SF3B3;SNRPD3;LSM2;LARP7
prerank,nuclease activity (GO:0004518),-0.28570064290345193,-0.9240291101346862,0.5940366972477065,0.8765100041624352,1.0,12/52,17.38%,ENPP1;RNASE4;N4BP2;ERCC5;REXO4;SAMHD1;ZC3H12A;DNASE1L1;NME1;ISG20L2;RNASEL;RNASE12
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4408942303416883,0.9207261254323947,0.5427350427350427,0.7929978831854697,1.0,6/10,10.19%,PRKAR1B;PKIA;CXCL10;PRKAR2B;PRKAR2A;PRKAR1A
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.2896919710863448,-0.9191144065474037,0.5818181818181818,0.883750791044913,1.0,8/46,11.96%,EXT1;LARGE1;HEXA;HEXB;MGAT1;B3GALNT1;MGAT2;EXTL2
prerank,phosphatase binding (GO:0019902),0.29627692289876134,0.9189013404226878,0.5569044006069803,0.7930335873800061,1.0,8/105,5.43%,ITGA1;MAP3K5;PTK2;PIK3R1;SPRED1;MYO16;JAK1;ROS1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.22445367028317684,-0.916519648886103,0.7245283018867924,0.8860433572218078,1.0,49/232,16.97%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;RNF125;MDM2;TRIM63;CBX4;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,adenyl nucleotide binding (GO:0030554),-0.3974866212239169,-0.9154702548020601,0.5752380952380952,0.8807962577302166,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3974866212239169,-0.9154702548020601,0.5752380952380952,0.8807962577302166,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3910003313722539,-0.9149000755432651,0.5808823529411765,0.8782807149815304,1.0,6/12,20.84%,CNOT7;NOCT;CNOT8;TOE1;PNLDC1;PAN3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.441643757700102,0.9147883574135691,0.5239085239085239,0.7976249492764974,1.0,2/10,4.44%,SLCO3A1;SLCO5A1
prerank,GTPase binding (GO:0051020),0.2700820174880934,0.914463051152135,0.6097222222222223,0.7949228724729188,1.0,31/194,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;SPTBN1;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;ATG16L1;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3009529246716905,-0.9128548681607997,0.5856236786469344,0.8789238315708048,1.0,12/37,20.75%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA
prerank,mRNA methyltransferase activity (GO:0008174),0.41944684143792443,0.9114214065831784,0.5217391304347826,0.7971307517317908,1.0,4/12,17.92%,TRMT61A;RNMT;TRMT10C;NSUN2
prerank,ribosomal large subunit binding (GO:0043023),0.4295556149149968,0.9106689057923524,0.5323275862068966,0.7952863723178544,1.0,4/11,11.18%,CPSF6;NMD3;MALSU1;EIF6
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.41621574792687394,0.9099258507511147,0.5365344467640919,0.7934064529620536,1.0,1/12,1.10%,CDK6
prerank,glucose transmembrane transporter activity (GO:0005355),0.39849708089346475,0.9082720736935025,0.5382830626450116,0.7931679556937133,1.0,3/17,8.29%,SLC5A1;SLC2A6;SLC2A3
prerank,nuclear receptor binding (GO:0016922),-0.2448094302398542,-0.9045390227098193,0.6836158192090396,0.8936528235037535,1.0,21/111,13.15%,SMAD3;FOXP1;LCOR;ESR1;DDX5;TACC2;TCF7L2;LEF1;TAF1;TMF1;THRAP3;PRKCB;STAT1;HIF1A;NR4A2;MMS19;KDM3A;NSD1;TRIP6;CALR;PPID
prerank,telomerase RNA binding (GO:0070034),-0.33608490830519944,-0.9040036051439793,0.5925155925155925,0.8909680152964179,1.0,10/22,27.12%,TEP1;SMG6;NAF1;PINX1;XRN1;SMG5;TENT4B;WRAP53;NHP2;SNRPB
prerank,MHC class II protein complex binding (GO:0023026),-0.38485820521181147,-0.8985426188666542,0.6034816247582205,0.8994069870296767,1.0,4/11,24.44%,ANXA11;HSP90AB1;CD81;YWHAE
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.39622866899412496,0.897709459147484,0.555793991416309,0.8092381419828224,1.0,3/15,10.26%,PIK3R1;SOCS5;SOCS6
prerank,palmitoyltransferase activity (GO:0016409),0.35965988758271256,0.8974467001640698,0.5895372233400402,0.8064584500653942,1.0,8/28,13.53%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3726340206141677,-0.8966389711099124,0.5930902111324377,0.899849444836228,1.0,8/14,37.73%,PRORP;ELAC2;RPP38;TSEN2;POP1;TSEN34;RPP21;RPP40
prerank,histone demethylase activity (GO:0032452),-0.3164042392437407,-0.8964814223462275,0.6170634920634921,0.8964824105240309,1.0,6/27,17.22%,KDM7A;KDM5B;JARID2;KDM3A;KDM6B;FBXL19
prerank,growth factor receptor binding (GO:0070851),0.29747598319294416,0.8953851359890209,0.6142857142857143,0.8068603114406072,1.0,12/95,10.21%,PDGFRB;GLMN;LINGO1;ERBB4;IL1B;FGF2;IL4;FGF10;IL12RB1;PDGFB;CNOT9;HIP1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.41722187339840466,0.8952257785856639,0.5704845814977973,0.80389865953767,1.0,1/13,0.19%,PDGFRB
prerank,acylglycerol lipase activity (GO:0047372),-0.3967558456104763,-0.8937420056402335,0.6065259117082533,0.8986357740945078,1.0,3/11,13.02%,MGLL;LIPE;ABHD16A
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.40421657381014836,-0.8928457508835003,0.6059479553903345,0.8966744695460689,1.0,3/10,14.54%,SHANK3;GNAS;SHISA7
prerank,fatty acid synthase activity (GO:0004312),-0.3970785770469979,-0.8899476769600694,0.6353383458646616,0.8990827672174908,1.0,3/10,23.82%,ELOVL7;ELOVL1;OXSM
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3006725700952031,-0.8895042440057502,0.643312101910828,0.896340339434008,1.0,14/33,25.65%,RNF19A;RNF144B;RNF185;RNF125;PPARA;ANKIB1;UBE3D;PARK7;RNF217;RNF144A;RNF19B;FOXL2;RPS3;PRKN
prerank,protein tyrosine kinase activity (GO:0004713),0.2888528380477996,0.8894027640754136,0.6234375,0.8112370342483258,1.0,23/108,12.65%,PDGFRB;ROR1;PTK2;PEAK1;FRK;MERTK;ERBB4;AXL;JAK1;RYK;ROS1;NTRK2;TTBK1;CSK;LYN;EPHA2;ABL2;HIPK1;EPHA10;TEC;EPHB1;SRC;FGFR3
prerank,transferrin receptor binding (GO:1990459),0.4177139390997181,0.8890628696300499,0.5673913043478261,0.8085883784928107,1.0,1/10,2.07%,RGMA
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.41872735329382305,0.8886129814373467,0.5767543859649122,0.8061267579185913,1.0,2/10,6.32%,OTUD5;DESI2
prerank,peptidase activator activity (GO:0016504),-0.3255532061088976,-0.8864597620702626,0.6324626865671642,0.8991522319492489,1.0,6/22,22.40%,CAV1;PSME2;PCOLCE;PSME3;VCP;CLPX
prerank,GTPase activity (GO:0003924),0.26328378818939085,0.8813368277324449,0.6477272727272727,0.8160864409187084,1.0,20/192,8.87%,RASL12;RERG;RND3;AGAP2;GNAZ;RAB8B;RAC3;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;RAB38;GNA12;RNF112
prerank,phosphatase inhibitor activity (GO:0019212),0.3748047899947834,0.8766528456543824,0.6042553191489362,0.8211687409054989,1.0,9/20,22.03%,PTN;SET;URI1;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.34709612419757646,-0.8731632360577406,0.6262230919765166,0.9233573575360455,1.0,8/16,26.83%,CD38;MACROD1;TDG;ADPRS;NEIL3;RPS3;NEIL1;NTHL1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3732744982218361,0.871281388617593,0.5824847250509165,0.8244211466511496,1.0,2/21,3.46%,CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3732744982218361,0.871281388617593,0.5824847250509165,0.8244211466511496,1.0,2/21,3.46%,CDK6;CDK15
prerank,O-methyltransferase activity (GO:0008171),-0.39427233596931605,-0.8690174919733454,0.6691176470588235,0.9282917391833717,1.0,4/10,32.58%,CMTR1;FTSJ3;ASMT;BCDIN3D
prerank,translation initiation factor activity (GO:0003743),-0.28684250966773495,-0.8668082429063411,0.6866666666666666,0.9292013323577976,1.0,16/36,30.58%,EIF4A1;EIF2S2;EIF4G3;MTIF3;EIF4A2;EIF5B;EIF2B2;EIF4E2;EIF1B;EIF2B5;EIF3B;EIF3H;EIF2B4;EIF2D;AGO2;EIF3D
prerank,RNA stem-loop binding (GO:0035613),-0.3707734767047894,-0.8656421142131915,0.6552380952380953,0.9279348645671807,1.0,4/12,12.44%,RC3H2;MYH10;ZC3H12A;CPEB3
prerank,phosphatase activity (GO:0016791),-0.2540393293429068,-0.8653437259915996,0.7559055118110236,0.9247462694780479,1.0,31/73,29.87%,PLPP3;PTPRJ;ALPL;DUSP12;NOCT;PPP1CB;DUSP16;PXYLP1;PLPP1;EPHX2;PGAM5;LPIN3;PGP;DUSP10;DUSP23;LHPP;PLPP4;CILP;NUDT16;DUSP15;INPP5K;NT5C;PPP5C;CILP2;PLPPR4;ACP3;PLPP2;DUSP26;PPP1CA;DUSP8;DUSP4
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.41430340121330167,0.8630940973801094,0.5874439461883408,0.8358971622215163,1.0,5/10,19.44%,SETMAR;SETD3;NSD2;NSD3;SETD5
prerank,methyl-CpG binding (GO:0008327),0.3578938861872113,0.862744577343786,0.6279527559055118,0.8333095492855849,1.0,4/22,10.73%,CDX1;MECP2;LHX4;PRMT1
prerank,copper ion binding (GO:0005507),-0.27887623260219574,-0.8617659818387575,0.6869565217391305,0.9281551624982284,1.0,5/42,7.43%,MOXD1;PAM;ATOX1;LACC1;P2RX4
prerank,ribonuclease activity (GO:0004540),-0.2615416163885622,-0.8608639361183679,0.7065727699530516,0.9263094077095343,1.0,14/56,20.39%,CNOT7;RNASE4;NYNRIN;SMG6;SAMHD1;ZC3H12A;ERN1;INTS11;EXOSC5;RNASEL;ELAC2;RNASE12;AGO1;DICER1
prerank,nucleosomal DNA binding (GO:0031492),-0.32542311412724073,-0.8596294073038039,0.6484848484848484,0.9250493803794181,1.0,6/21,22.86%,H3-3A;HDAC1;ACTB;SMARCC1;MBD2;SMARCA4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.36889420986024485,-0.8545323136995701,0.6666666666666666,0.9314065935827707,1.0,5/12,20.22%,MTPAP;TENT5A;PAPOLB;TENT5C;TENT4B
prerank,motor activity (GO:0003774),0.2993223162977212,0.8499842412703078,0.6507666098807495,0.8530987558360388,1.0,14/60,15.94%,STARD9;MYH9;KIF26B;MYO6;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,microtubule minus-end binding (GO:0051011),-0.3588725067826296,-0.8475821435364199,0.6878504672897197,0.9412048843640252,1.0,5/13,29.32%,MACF1;TUBGCP5;NUMA1;CAMSAP1;TUBGCP6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.2856188191044448,-0.8457136933504701,0.70995670995671,0.9410468046371282,1.0,9/33,17.78%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;XRN1;PNPT1;TOE1;PNLDC1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2022051613768156,-0.8455744303451745,0.9254385964912281,0.9376354875746932,1.0,95/269,28.98%,SNCAIP;SMAD3;EGFR;SMAD6;FOXO1;FHIT;SNX9;SMAD7;SKI;PARP9;ARRB1;STAT2;TNFRSF1B;IKBKE;TXNIP;MFHAS1;STAT1;HSPA5;ACTG1;POLR2A;FZD4;DTX3L;HGS;TRIOBP;HIF1A;PCBP2;BECN1;CASP8;ARRDC1;PML;PATZ1;RPL11;CUL4A;MDM2;RELA;SLC22A18;UBB;CALR;PRKACB;ELOB;TUBA1B;HSP90AB1;NEDD8;WASHC1;DTX1;FZD8;RPL23;TMBIM6;CBS;RNF40;SMG5;RIPK1;GABARAPL1;NFKBIA;ERLIN2;EIF4E2;NPLOC4;TRIB1;PPARGC1A;VCP;PIAS4;IKBKG;CDK5RAP3;UBE2L6;RFFL;UBXN1;CUL5;WRAP53;HSPA9;USP2;CHEK2;RNF8;BRCA1;YWHAE;PRKN;TRIP4;TP53;BAG5;KCNH2;SCAMP3;BCL10;ATXN3;FZD5;PRR7;TRIB3;HSPA1B;CLU;SLF1;ATP6V0C;TNK2;LAPTM5;BAG1;SMAD2;ISG15;JUN
prerank,ribosome binding (GO:0043022),0.3150935336291476,0.8454895931514202,0.6618181818181819,0.8578702195630975,1.0,17/46,21.58%,CPEB1;MRPS27;YTHDF3;SRP72;EIF3C;NCLN;EIF6;GTPBP6;CPEB4;C1QBP;FMR1;NAA15;OXA1L;EEF2;SEC61A2;SRP68;EIF2S1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4047413601715094,0.8449205626229401,0.6051502145922747,0.8555960985599627,1.0,3/10,17.43%,DCLRE1B;TATDN1;APEX1
prerank,phosphate ion binding (GO:0042301),0.40620748289592046,0.8445228451038947,0.623059866962306,0.8530090947686867,1.0,2/10,7.43%,RPH3A;MTHFD2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.36452572494614127,-0.8439764655227796,0.6698656429942419,0.9369937214798136,1.0,6/11,26.83%,APEX2;NEIL3;RPS3;NEIL1;APLF;NTHL1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2446783971020419,0.8427884514037512,0.7550200803212851,0.8528820508289541,1.0,25/248,8.87%,RASL12;RERG;MYH9;RND3;AGAP2;GNAZ;RAB8B;ABCD2;TOR1B;RAC3;ATAD1;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;MYO6;RAB38;GNA12;RNF112
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.265701533510158,-0.8415695142187662,0.726457399103139,0.9380469169707292,1.0,19/49,36.94%,ZFAND6;IKBKE;OPTN;MINDY1;WDR81;PSMD4;BABAM2;VCP;IKBKG;UBXN1;DZIP3;ABRAXAS2;MINDY2;PARP10;HDAC6;AGAP3;RAD23A;TAB2;ZRANB3
prerank,chemoattractant activity (GO:0042056),-0.30249785434774057,-0.8408282069025256,0.685370741482966,0.9358994348217794,1.0,4/26,6.31%,BMP4;VEGFD;VEGFC;CCL15
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.35106448012237046,0.8406306079811368,0.6242171189979123,0.8535843248409304,1.0,7/24,15.63%,AK1;ITPKB;AK8;AK7;AK5;AK3;AK4
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.39104968224454023,0.8395980403206692,0.6075156576200418,0.8522254005119473,1.0,2/13,8.24%,SREBF2;ECI1
prerank,Toll-like receptor binding (GO:0035325),-0.36334838478063075,-0.8390168953097463,0.6936416184971098,0.9357081354644889,1.0,7/11,43.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;TLR2;S100A9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.37726842841515734,-0.8383838645623305,0.6666666666666666,0.9333645608938479,1.0,1/10,0.43%,DPYSL3
prerank,histone methyltransferase activity (GO:0042054),-0.29380578186676226,-0.8361131835558068,0.6950959488272921,0.933998459112337,1.0,5/32,10.03%,SMYD3;SETD7;KMT5A;CARM1;EHMT1
prerank,hexosaminidase activity (GO:0015929),0.38818345727993625,0.8355266969570848,0.631004366812227,0.8560811166665939,1.0,2/12,2.63%,CEMIP2;HYAL4
prerank,CXCR chemokine receptor binding (GO:0045236),0.3960751520046366,0.8299657906696443,0.6065934065934065,0.8623472900555421,1.0,3/11,12.77%,CXCL10;CXCL5;YARS1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3787616006810768,0.8287806550100109,0.6165254237288136,0.8610170012206454,1.0,1/14,1.67%,RDH5
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3293316883778454,-0.828741294357358,0.7026022304832714,0.9438963641533047,1.0,5/16,17.21%,SLC22A4;SLC25A17;SLC22A5;SLC22A2;SLC25A26
prerank,water transmembrane transporter activity (GO:0005372),-0.36247805911429964,-0.8263091220600789,0.672514619883041,0.9447723027942554,1.0,1/11,1.41%,PDPN
prerank,deubiquitinase activity (GO:0101005),-0.2313522740755522,-0.8260541368219189,0.8315508021390374,0.9416725528844169,1.0,15/88,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;MINDY1;USP49;MPND
prerank,cytokine receptor activity (GO:0004896),0.27862940028954963,0.8250554391045068,0.6904024767801857,0.8642527055210664,1.0,10/83,8.74%,IL15RA;IL1RL2;IL17RD;GFRA2;CCRL2;IL2RA;IL12RB1;CCR9;ACKR2;OSMR
prerank,N-acetyltransferase activity (GO:0008080),-0.3102618780218649,-0.8191784741425677,0.687984496124031,0.950727352551169,1.0,11/19,44.91%,KAT2B;NAT10;SAT1;NAA80;NAT2;NAT14;NAA10;AANAT;NAT8;NAT1;SMARCE1
prerank,hormone activity (GO:0005179),-0.2500937507415954,-0.8190009309392143,0.7980769230769231,0.9475340616444891,1.0,10/54,23.79%,IGF1;METRNL;CCL25;PTHLH;EDN3;AGT;PPY;GNRH1;AGRP;PENK
prerank,phosphatase activator activity (GO:0019211),-0.33326980730340666,-0.817530820937008,0.701067615658363,0.9465445422768053,1.0,4/14,18.58%,CALM2;FRS2;CALM1;PPP2R5C
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3481792172206846,0.8129636143571293,0.6505791505791506,0.8818885519026491,1.0,6/21,17.93%,CHRNA3;CHRNA7;GRIK2;CHRNB2;P2RX5;GLRB
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.33528563763748964,0.8128175363396418,0.6708333333333333,0.8788659127120975,1.0,6/24,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC17;ZDHHC21;ZDHHC23
prerank,mRNA 3'-UTR binding (GO:0003730),-0.23016421661806782,-0.8124833219965482,0.8567415730337079,0.9520274357984041,1.0,21/79,19.27%,CELF2;RBMS2;LARP4B;DDX5;RPL41;CPEB2;IGF2BP2;ZC3H12A;PUM1;CPEB3;YBX3;LARP1;AUH;GEMIN5;FXR2;ELAVL1;RNF40;RPS7;CSDC2;ZFP36L2;PABPC4L
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.31903825611589526,0.8122459310587381,0.6872659176029963,0.8767394032669196,1.0,7/31,10.88%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.23003054211807972,-0.8111803069667616,0.8157894736842105,0.9507250640086858,1.0,14/83,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;USP49;MPND
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.39131044972614737,0.8108372933788897,0.6535796766743649,0.8759728386055328,1.0,3/11,13.00%,PRMT1;PRMT3;PRMT7
prerank,alanine transmembrane transporter activity (GO:0022858),-0.33622981411901565,-0.8093855565410776,0.707089552238806,0.950401686267676,1.0,3/12,11.28%,SLC6A6;SLC38A5;SLC3A2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3580089391190696,0.8071672131045807,0.6602972399150743,0.8791365550873635,1.0,2/14,4.37%,BLVRB;DHFR
prerank,channel activity (GO:0015267),-0.26520364727081636,-0.8061837676890484,0.7986270022883295,0.9525185254093016,1.0,7/41,15.56%,PDPN;MCUB;TRPV4;MPV17;TMEM120B;CHRNB1;AQP11
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3070516609317586,0.8061287133093277,0.6829710144927537,0.8777514164067101,1.0,4/38,3.58%,PIK3R1;NCK2;LDLRAP1;SH2B3
prerank,microtubule motor activity (GO:0003777),0.291584635036963,0.802234162496192,0.7100175746924429,0.8809443275482355,1.0,12/51,15.94%,STARD9;KIF26B;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,hormone receptor binding (GO:0051427),0.3648162526099613,0.8001736362000496,0.6647286821705426,0.881114162669922,1.0,3/14,7.66%,JAK1;CCK;NCOA6
prerank,anion:anion antiporter activity (GO:0015301),-0.32493394079233795,-0.7992297291903395,0.7381889763779528,0.9608250927312504,1.0,3/17,8.77%,SLC26A7;SLC26A2;SLC25A4
prerank,glutathione transferase activity (GO:0004364),-0.294207815322545,-0.7972270511340489,0.7590618336886994,0.9606027532948741,1.0,5/23,14.24%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.38485533533705385,0.7961153816037794,0.709051724137931,0.8848671170922268,1.0,3/10,8.59%,HEXIM1;CDKN1A;INCA1
prerank,alkali metal ion binding (GO:0031420),0.3692337755867535,0.795965613088835,0.6733466933867736,0.8819681834967542,1.0,1/13,1.22%,ATP1A2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3166918647490488,-0.7952840831066768,0.7411545623836127,0.9603438102837366,1.0,8/16,40.14%,PIR;ALOX12;CDO1;HGD;ALOXE3;HAAO;ALOX5;ADI1
prerank,deoxyribonuclease activity (GO:0004536),-0.32620136138670264,-0.7921810033065695,0.7382671480144405,0.9621581132278005,1.0,6/14,26.31%,ERCC5;DNASE1L1;NME1;DFFB;RPS3;APLF
prerank,phosphatidate phosphatase activity (GO:0008195),-0.335618349117212,-0.7852513531727473,0.7335834896810507,0.9694226954059911,1.0,6/13,27.19%,PLPP3;PLPP1;LPIN3;PLPP4;PLPPR4;PLPP2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.37185428708400264,0.7824535989181656,0.6596736596736597,0.90104343528283,1.0,2/10,8.24%,HADHB;ECI1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.271722133621239,-0.7803800410952451,0.8142292490118577,0.9735277278027726,1.0,4/30,7.95%,CAST;GAS6;BIRC3;CST3
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24286903550260702,-0.7793797801430653,0.8344988344988346,0.9717534730638561,1.0,14/49,17.09%,MPPED2;PTPRJ;DUSP12;PPP1CB;SAMHD1;DUSP16;PXYLP1;EPHX2;PGAM5;PGP;SMPDL3A;DUSP10;DUSP23;LHPP
prerank,receptor antagonist activity (GO:0048019),-0.3094602343083799,-0.7789910744398901,0.7735124760076776,0.9688770643175613,1.0,1/17,1.79%,DKK3
prerank,exonuclease activity (GO:0004527),-0.24099020876002342,-0.7764568244827798,0.8240963855421687,0.9693722435389948,1.0,10/46,15.38%,ENPP1;CNOT7;ENPP3;DCLRE1C;REXO4;ZC3H12A;APEX2;ISG20L2;RAD50;EXOSC5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.32730056805023444,-0.7756092425550972,0.7661290322580645,0.9672289703584084,1.0,1/13,2.48%,AGPAT4
prerank,receptor tyrosine kinase binding (GO:0030971),0.28270024647485786,0.7732645276406303,0.7583187390542907,0.9123629211225873,1.0,10/56,11.03%,PIK3R1;NRG1;SH2B3;NRG3;PITPNM2;SOCS5;IRS1;SHC4;BLNK;CBLB
prerank,retinoid X receptor binding (GO:0046965),0.36900436645580004,0.7714442783115822,0.7020833333333333,0.9120811655558803,1.0,3/11,7.66%,TACC1;ARID5A;NCOA6
prerank,CoA-ligase activity (GO:0016405),-0.31604948008744493,-0.7700025385374938,0.7661596958174905,0.9726621401480338,1.0,1/14,2.17%,ACSS3
prerank,solute:sodium symporter activity (GO:0015370),-0.27343102551758497,-0.76815565618518,0.8008658008658008,0.9718657525381419,1.0,3/27,9.26%,SLC4A10;SLC20A2;SLC5A6
prerank,NF-kappaB binding (GO:0051059),-0.2806399846329085,-0.7676739457635342,0.7818930041152263,0.9691093073188402,1.0,7/24,22.84%,ANXA4;HDAC1;RELA;TAF4B;NFKBIA;CDK5RAP3;SETD6
prerank,transcription corepressor binding (GO:0001222),0.31131232675120524,0.7664465677352085,0.7427466150870407,0.9164916062724046,1.0,3/27,5.75%,RORA;PER2;CNOT2
prerank,single-stranded DNA helicase activity (GO:0017116),0.32038720351168887,0.7655738332748794,0.7079107505070994,0.91469073522589,1.0,5/19,16.87%,MCM6;WRNIP1;MCM7;MCM2;PIF1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28831132513066554,-0.76495615984509,0.7686274509803922,0.9697273507100158,1.0,12/20,40.85%,SETD7;KMT5A;EHMT1;ETFBKMT;SETD6;SETD4;EEF1AKMT3;EEF2KMT;METTL21C;VCPKMT;EEF1AKMT4;SMYD2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.22215351308941497,-0.7635222142747871,0.8826530612244898,0.9685063174044147,1.0,12/75,16.60%,ABCC4;DHRS3;CRYL1;SORD;ME1;DHDH;BDH1;PGD;ADH1A;BDH2;AKR1A1;HSD17B7
prerank,ATPase regulator activity (GO:0060590),-0.2518503068787207,-0.763434987000436,0.8314350797266514,0.965290118667289,1.0,12/38,22.02%,ATP1B3;FNIP1;BAG3;TOR1AIP1;DNAJB2;DNAJC24;PFN1;DNAJB6;DNAJC15;DNAJC10;BAG2;PLN
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.29362730753766453,0.7629707393642762,0.7588126159554731,0.9154613431829373,1.0,7/34,10.88%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,phospholipase A2 activity (GO:0004623),-0.2769745575592095,-0.7606751364058908,0.8232931726907631,0.9659949518605092,1.0,3/26,13.21%,PLA2G4A;PLA2G6;PLA2G15
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.29534476175978425,0.7604614440404568,0.7357142857142858,0.9162032907474662,1.0,9/33,14.06%,NCOA3;CCAR2;TBP;RPRD1B;DRAP1;CTR9;HNRNPU;URI1;UVSSA
prerank,damaged DNA binding (GO:0003684),0.2785260303639689,0.7585002486913869,0.7708333333333334,0.9161151508575001,1.0,17/44,23.23%,DCLRE1B;FANCG;ERCC4;RAD1;AUNIP;EP300;XPC;SMC6;RPA2;APEX1;SDE2;DDB2;MPG;CREBBP;XRCC1;PNKP;RAD18
prerank,1-phosphatidylinositol binding (GO:0005545),0.3423179713346783,0.7579354997163394,0.7124735729386892,0.9138024681010617,1.0,3/15,5.90%,SCARB1;EPB41;WDFY3
prerank,RNA cap binding (GO:0000339),-0.30033320416313436,-0.7575209603323525,0.7786116322701688,0.9669812755386678,1.0,5/16,18.29%,CYFIP2;EIF4A1;LARP1;GEMIN5;EIF4E2
prerank,lipid phosphatase activity (GO:0042577),-0.318314660158975,-0.7565947164845915,0.7923809523809524,0.9650892421786593,1.0,6/14,27.19%,PLPP3;PLPP1;EPHX2;INPP5K;PLPPR4;PLPP2
prerank,acid-thiol ligase activity (GO:0016878),-0.3137681954477819,-0.7525474905381773,0.7504835589941973,0.9673966321809638,1.0,1/13,2.17%,ACSS3
prerank,four-way junction DNA binding (GO:0000400),-0.2999289614555367,-0.7503808183671145,0.8011363636363636,0.9671232593814355,1.0,11/17,44.16%,RAD51B;HMGB2;RAD51C;MSH6;FANCM;ABL1;WRN;RAD51D;HMGB3;GEN1;YY1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2147314692373789,0.750332224597243,0.9478260869565217,0.9223265778710167,1.0,67/346,16.36%,NEDD4L;TNFAIP1;DTX3;UBR1;HECW2;BTRC;TRIM9;RNF150;CUL3;RBX1;TRAF5;PELI2;SIAH2;MYLIP;TRIM43;TRIM62;UBE2QL1;CBLL1;UBE2E3;NEURL1B;NEURL3;RCHY1;UBR3;HACE1;UBE2J2;TRAF3;VPS18;UBE2E1;SIAH3;MIB2;RNF25;KCTD13;FBXO24;RNF112;HECW1;UBE2G1;BIRC6;VPS11;RLIM;TSPAN17;CNOT4;AKTIP;CBLB;TRIM2;PPIL2;UBE3A;UBR2;RNF121;PPP1R11;RNF114;TRAF6;RMND5B;TRAF2;KLHL13;TRIM45;LMO7;ARIH1;ZFP91;RNF103-CHMP3;PEX12;RNF138;ZNRF2;TRIM37;ERCC8;NFX1;RNF6;RNF166
prerank,vitamin D receptor binding (GO:0042809),0.32925341695728993,0.7496159294293514,0.7457264957264957,0.920169079710861,1.0,9/14,28.56%,MED13;MED1;MED4;MED30;MED16;TAF7;MED14;SNW1;MED17
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3341000067120307,-0.7480352682210087,0.7862745098039216,0.9667981097932253,1.0,1/10,1.07%,B4GALT1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.25495711572016655,-0.7478643388492058,0.84472049689441,0.963763512212147,1.0,19/34,40.85%,SMYD3;SETD7;KMT5A;EHMT1;EZH2;SETDB1;ETFBKMT;SETD6;SETD4;CAMKMT;DOT1L;EEF1AKMT3;EEF2KMT;METTL21C;KMT2E;VCPKMT;EEF1AKMT4;N6AMT1;SMYD2
prerank,adenylyltransferase activity (GO:0070566),-0.2779960008800531,-0.7469396948741268,0.8178217821782178,0.9617792173073602,1.0,10/21,32.79%,OAS2;KARS1;MTPAP;NMNAT1;PAPOLB;TENT4B;ABL1;OASL;GPHN;FICD
prerank,N-methyltransferase activity (GO:0008170),0.3171629817056008,0.7468648054319581,0.740506329113924,0.9211304222492974,1.0,9/20,22.52%,TRMT1;RNMT;TRMT11;PRMT1;SETD3;METTL18;TFB2M;TRMT1L;DIMT1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3259442249351191,0.7466852914904887,0.7086776859504132,0.9182689232842306,1.0,4/17,10.73%,BAAT;ACOT12;PPT1;ACOT2
prerank,Hsp90 protein binding (GO:0051879),0.2915233667500831,0.7465713065498382,0.7504873294346979,0.9153263592966293,1.0,1/33,0.64%,SLC12A2
prerank,ubiquitin protein ligase binding (GO:0031625),0.2185952419309438,0.7443310759850796,0.9267015706806283,0.9156410877766019,1.0,38/254,12.06%,GLMN;VCL;FZD6;USP25;PRR5L;PTPN22;CUL3;RBX1;ABI2;TRAF5;JAK1;TRIB2;FAF2;SCN5A;MAGEC2;UCHL1;SPOPL;PRKAR2B;YWHAZ;UBE2J2;TRAF3;BLZF1;CDKN1A;GPR37;PRKAR2A;SLF2;UBE2G1;DET1;NKD2;NEK6;PRKAR1A;OTUB1;AXIN2;RB1;GPI;NLK;APC;SPOP
prerank,kinase inhibitor activity (GO:0019210),0.29249446743173324,0.7441364546832627,0.7934990439770554,0.912849858261413,1.0,6/33,10.76%,SPRY4;HEXIM1;SNCA;TAOK3;CDKN1A;PRKRIP1
prerank,DNA replication origin binding (GO:0003688),0.31370243520206986,0.74295731018959,0.7683397683397684,0.9115615198876855,1.0,6/23,17.61%,KAT7;MCM6;MCM7;MCM2;ORC4;DDX11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.2736490548006432,-0.7352194640070429,0.8190661478599222,0.9737674395357307,1.0,4/22,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.27032759820453134,-0.7335583300070394,0.8663967611336032,0.9726307278883105,1.0,2/25,1.69%,EFEMP1;TGFA
prerank,histone methyltransferase binding (GO:1990226),-0.3249417953112257,-0.7316903044558004,0.8377862595419847,0.9717723074665467,1.0,1/11,1.65%,LCOR
prerank,phosphotyrosine residue binding (GO:0001784),0.2886646774099024,0.7312220693162403,0.7863894139886578,0.9253443214108339,1.0,3/37,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2703139438315385,-0.7290896938653232,0.8242424242424242,0.9715328039458199,1.0,8/22,36.94%,IKBKE;OPTN;WDR81;IKBKG;MINDY2;PARP10;TAB2;ZRANB3
prerank,endopeptidase activator activity (GO:0061133),-0.3330559572071796,-0.7285692957699644,0.8150807899461401,0.968909528150023,1.0,6/10,43.84%,PSME2;PSME3;VSIR;APH1A;PSENEN;PSMD14
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3265291743613758,0.7275568093184702,0.75,0.9274302958236909,1.0,7/15,22.43%,KMT2B;SETMAR;SETD3;KMT2A;KMT2D;WDR5;SETD1A
prerank,Notch binding (GO:0005112),0.306563129486739,0.7260422095865281,0.7704280155642024,0.9265354145209787,1.0,4/22,4.35%,DLL3;CHAC1;CUL3;DNER
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.27325581976677255,-0.7258534192149527,0.8329979879275654,0.9691614241354065,1.0,3/21,9.31%,FGF1;KL;FRS2
prerank,GABA receptor binding (GO:0050811),0.34144877303469867,0.7209508984642685,0.775175644028103,0.930419555501817,1.0,6/11,22.03%,PLCL2;TRAK1;TRAK2;JAKMIP1;GABARAP;GABARAPL2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3383755962842078,0.7152234924644325,0.7304347826086957,0.9352318551171062,1.0,11/11,66.19%,HCN2;CNGB1;HCN1;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,protein phosphorylated amino acid binding (GO:0045309),0.27301023043406797,0.7145067471905093,0.8288288288288288,0.9330575336050845,1.0,3/42,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2876951378841977,-0.711440489451012,0.85,0.9828733044124256,1.0,1/15,2.48%,AGPAT4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2959885581876691,-0.7068906152324421,0.8460176991150442,0.9845647572783274,1.0,7/13,45.54%,DNASE1L1;DICER1;SLX4;EXO1;FEN1;GEN1;FAN1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.27743749257791706,0.7067220491252891,0.8164435946462715,0.9403146431141833,1.0,9/33,17.12%,NCOA3;CCAR2;RPRD1B;CTR9;MAF1;HNRNPU;URI1;UVSSA;RRN3
prerank,chemokine receptor binding (GO:0042379),-0.23499023628344484,-0.7066557104525946,0.8950749464668094,0.9816022899824836,1.0,21/35,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;ITCH;CX3CL1;CCL28;CCL5;CCL11;CX3CR1;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2512132633253927,-0.7012437565055387,0.8847736625514403,0.9844652715636311,1.0,4/27,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.28009962367128505,-0.6991235213477766,0.8557312252964426,0.9835530551277161,1.0,6/17,24.76%,LBR;DPYD;BDH2;DECR1;PTGR2;PTGR1
prerank,RNA polymerase binding (GO:0070063),0.29942040120052765,0.6940638240348775,0.7938342967244701,0.9533414524684924,1.0,4/18,11.57%,PHRF1;BIN1;TCERG1;YTHDC2
prerank,endoribonuclease activity (GO:0004521),-0.23838929980313128,-0.6938006658307534,0.9059304703476483,0.9858962565206573,1.0,17/32,37.99%,NYNRIN;SMG6;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;ZC3H12B;RNASEK;AGO2;ENDOU;EXOG;ENDOG;RIDA;CPSF3;ZC3H12D
prerank,endonuclease activity (GO:0004519),-0.21866713464953502,-0.6920175516344076,0.9279069767441861,0.9845906374009881,1.0,18/49,29.57%,N4BP2;NYNRIN;ERCC5;SMG6;REXO4;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;RPS3;ZC3H12B;APLF;RNASEK;NTHL1;AGO2;ENDOU
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.298398905565244,-0.691887607446822,0.8589511754068716,0.9815671900624912,1.0,4/12,18.29%,CYFIP2;LARP1;GEMIN5;EIF4E2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.33247796608955005,0.6917759830721701,0.7857142857142857,0.9530868713572386,1.0,3/10,17.45%,NAA11;NAA30;NAA15
prerank,ligand-gated calcium channel activity (GO:0099604),0.29934605171120293,0.6911051520341297,0.8084677419354839,0.950798727794475,1.0,6/19,15.87%,ITPR1;RYR2;RYR3;GRIN2B;RASA3;GRIN2A
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.23836836373849365,0.6876729625212011,0.9082125603864735,0.9518951296548985,1.0,20/69,19.01%,ZDHHC14;BAAT;PLAAT1;ZDHHC1;ZDHHC2;CERS4;ZDHHC16;PLA2G4E;KAT6A;GLYAT;EP300;ZDHHC17;ZDHHC21;HHAT;AWAT2;NAA15;ZDHHC9;SOAT2;CERS6;CERS5
prerank,serotonin receptor activity (GO:0099589),0.289418085669813,0.6862176449512628,0.8,0.9444345683880169,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.289418085669813,0.6862176449512628,0.8,0.9444345683880169,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.289418085669813,0.6862176449512628,0.8,0.9444345683880169,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3231901221574369,0.6827792756869558,0.7709251101321586,0.94526829321826,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3245231971916177,0.6801285768829028,0.8017057569296375,0.9452220521515468,1.0,4/10,18.20%,FUOM;RPE;GALE;GALM
prerank,3'-5' DNA helicase activity (GO:0043138),-0.27065781687713947,-0.6799507691074088,0.8831417624521073,0.9901549742526786,1.0,9/16,34.89%,ASCC3;NAV2;RECQL;ERCC3;FANCM;WRN;MCM5;HELQ;RECQL5
prerank,RNA polymerase II complex binding (GO:0000993),0.2648137739457469,0.6768200146625779,0.8424908424908425,0.9459689528836762,1.0,7/32,14.06%,NCOA3;CCAR2;RPRD1B;CTR9;HNRNPU;URI1;UVSSA
prerank,CoA hydrolase activity (GO:0016289),0.30063507028378644,0.6729907453866145,0.8174097664543525,0.9471410795443298,1.0,4/16,15.91%,BAAT;ACOT12;ACOT2;ACOT7
prerank,MHC protein binding (GO:0042287),-0.2620786340204918,-0.6711771124437977,0.8960784313725491,0.9953990246350658,1.0,6/20,28.09%,TAPBP;CD81;TUBB4B;TAP2;LAG3;TAP1
prerank,Hsp70 protein binding (GO:0030544),-0.2307793401050628,-0.6705543768500433,0.9230769230769231,0.9928335843627311,1.0,13/31,28.50%,HDAC8;ERN1;DNAJB2;PPEF2;PPID;DNAJC10;DNAJB12;RPS3;DNAJC2;DNAJC8;PRKN;IQCG;MVD
prerank,ion channel inhibitor activity (GO:0008200),0.26038255295171403,0.669360179518234,0.8576779026217228,0.9479707174849535,1.0,2/35,3.95%,NEDD4L;ITPR1
prerank,methyltransferase activity (GO:0008168),0.24302548059692375,0.668097030412722,0.8745519713261649,0.946327817841958,1.0,12/46,17.92%,NSUN3;AS3MT;TRMT11;EEF1AKMT1;PRMT1;GCSH;PRMT3;PRMT7;SUV39H1;GAMT;METTL4;NSUN2
prerank,protein phosphatase regulator activity (GO:0019888),0.24603971015844836,0.6675152213090941,0.8844765342960289,0.944020419738904,1.0,18/53,22.03%,PTN;PPP2R2A;ANKLE2;PPP1R16A;PPP2R5D;SET;PPP6R2;PPP4R4;MGAT5;CABIN1;SAG;PPP1R15A;PPP2R1A;PPP2R5B;LMTK2;CALM3;STYXL1;BOD1L1
prerank,miRNA binding (GO:0035198),-0.23252224380700975,-0.658506551515179,0.9245689655172413,1.0,1.0,8/30,19.17%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.23496948166969805,-0.6576567743492119,0.9191919191919192,0.9977579659717468,1.0,6/26,20.64%,CSGALNACT1;CHSY1;B3GALNT1;EXTL2;CHPF2;B3GALNT2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3085062622237736,0.6552782013622638,0.8228941684665226,0.9539564798698879,1.0,4/11,20.72%,RBX1;PPIL2;STUB1;UBE4A
prerank,solute:proton symporter activity (GO:0015295),-0.2642058709553407,-0.6549534829300556,0.9087523277467412,0.9967964435043123,1.0,2/16,10.60%,SLC2A13;SLC39A8
prerank,hydro-lyase activity (GO:0016836),0.2476396100458772,0.6524586637162961,0.9257246376811594,0.9539168042870595,1.0,5/41,8.24%,CA4;ACO2;HADHB;ALAD;ECI1
prerank,single-stranded DNA binding (GO:0003697),-0.18113596373142135,-0.6516635537505036,0.9943181818181818,0.9964413001268383,1.0,24/93,24.60%,SSBP2;SSBP1;RAD51B;RTF1;ERCC5;REXO4;PCBP2;SAMHD1;BRCA2;NABP1;RPA1;HMGB2;PARK7;MCMDC2;RAD52;TOP3A;NEIL3;MCM8;WBP11;RAD51;CDC45;ERCC1;RPA3;POLR2G
prerank,myosin V binding (GO:0031489),0.29214466267699907,0.6505060912869758,0.8375,0.9529265686271816,1.0,2/15,6.02%,RAB39B;RAB3B
prerank,glycine binding (GO:0016594),0.30308725594280406,0.648822476376158,0.8609406952965235,0.9516759209637834,1.0,4/11,21.36%,GRIN2B;SRR;GLRB;GRIN1
prerank,tRNA binding (GO:0000049),-0.20731981166943464,-0.6438112071268678,0.95,0.9996261808746925,1.0,10/43,19.41%,EEF1A1;KARS1;CARS1;ELP1;SARS1;XPOT;TYW5;TRNAU1AP;TRMT10B;NAT10
prerank,dynactin binding (GO:0034452),0.2972365562646432,0.6435135521840856,0.8329809725158562,0.9541240663349484,1.0,4/12,18.00%,HOOK3;BICD2;HTT;GSK3B
prerank,pyridoxal phosphate binding (GO:0030170),-0.2386872983693165,-0.6412356587537901,0.93,0.9984008568506783,1.0,10/20,33.11%,PYGB;OAT;CBS;AGXT;ABAT;PDXK;PNPO;PYGL;GLDC;SHMT1
prerank,tRNA methyltransferase activity (GO:0008175),0.28201557091612284,0.6406835834873027,0.8606060606060606,0.9538871368095615,1.0,2/16,9.72%,TRMT5;THUMPD2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21237820211575947,-0.6377338133667543,0.9535864978902954,0.9978238889806519,1.0,11/34,26.39%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;PNPT1;TOE1;PNLDC1;PAN3;EXOSC7;ANGEL2
prerank,growth factor activity (GO:0008083),0.21871712260468568,0.6345111321028915,0.9420062695924765,0.9566654965614206,1.0,8/74,9.28%,PTN;NRG1;NRG3;FGF2;IL4;FGF10;PDGFB;JAG1
prerank,neuropeptide binding (GO:0042923),0.27004903641468103,0.6339271683456786,0.8722109533468559,0.9543128741904233,1.0,2/18,8.14%,OPRK1;GPR37
prerank,telomeric DNA binding (GO:0042162),-0.2145153180629935,-0.6327929437639014,0.9449152542372882,0.998252822539965,1.0,7/32,22.33%,SMG6;UPF3A;RPA1;RAD50;SMG5;UPF2;ACD
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.28074930383548735,0.6282966181831676,0.8387096774193549,0.9563495687485825,1.0,2/14,6.32%,OTUD5;DESI2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2566748963855624,-0.6241092397672385,0.9102803738317757,1.0,1.0,6/14,25.46%,ACO1;ISCA2;RSAD2;EXO5;NDUFS1;SDHB
prerank,ribosomal small subunit binding (GO:0043024),-0.24276885570466022,-0.6238802615336895,0.9176706827309237,0.9980838285113137,1.0,5/17,19.05%,CPEB2;MTIF3;NME1;LARP1;EIF1B
prerank,ribonuclease P activity (GO:0004526),-0.2734204587910527,-0.6173465336632269,0.9047619047619048,0.9989883091146011,1.0,5/11,37.73%,PRORP;RPP38;POP1;RPP21;RPP40
prerank,endodeoxyribonuclease activity (GO:0004520),-0.236978977219566,-0.6163855992319912,0.9534883720930233,0.9965354103690901,1.0,11/20,36.99%,ERCC5;DCLRE1C;RAD50;ERCC1;RPS3;APLF;EXO1;EXOG;ENDOG;ZRANB3;FEN1
prerank,MHC class I protein binding (GO:0042288),-0.26586145964743035,-0.6163593185317601,0.9298892988929889,0.993510479713083,1.0,4/13,28.09%,TAPBP;TUBB4B;TAP2;TAP1
prerank,NADPH binding (GO:0070402),-0.26117318860379785,-0.6154293776890519,0.9332096474953617,0.991034572661264,1.0,4/13,27.28%,LBR;DECR1;GRHPR;MTRR
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.19911876392471806,-0.6103331112874204,0.9679358717434869,0.9911832833187308,1.0,9/35,23.95%,MTFMT;TARS2;FTO;ELAC2;TRIT1;PTRH2;TRMT13;FTSJ1;TRMT12
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.28725995346008854,0.6084942844824136,0.88125,0.9698910868380062,1.0,3/11,13.88%,RDH14;DHRS13;RDH12
prerank,regulatory RNA binding (GO:0061980),-0.19803999311169862,-0.6030160095020342,0.9752252252252253,0.9926894526511155,1.0,9/38,20.39%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1;DICER1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2584825057236054,-0.5906645360376528,0.9238095238095239,0.996248177088103,1.0,1/11,6.45%,DDAH1
prerank,CCR chemokine receptor binding (GO:0048020),-0.2076515913499852,-0.5897848978432704,0.9681093394077449,0.9936858400004686,1.0,21/28,52.69%,CCL15;CCL14;CCL25;CCL13;CCL19;CCR2;CCL2;NARS1;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2892586401013856,0.5879348955525235,0.8768898488120951,0.9824630003563688,1.0,5/11,22.11%,HNRNPA1;RPA2;TERF1;HNRNPA2B1;CTC1
prerank,carboxy-lyase activity (GO:0016831),-0.2143953650320793,-0.5815425987669326,0.9600798403193613,0.9948098474966488,1.0,5/23,22.15%,CSAD;ODC1;DDC;BCKDHA;AZIN1
prerank,nuclear import signal receptor activity (GO:0061608),0.25913846319502476,0.578358619270204,0.930379746835443,0.9859590473306606,1.0,4/15,20.99%,KPNA4;KPNA1;TNPO1;KPNA3
prerank,histone acetyltransferase binding (GO:0035035),-0.21674748509917044,-0.576360985666274,0.9647749510763209,0.9941081947886897,1.0,8/21,25.85%,STAT1;HIF1A;GLI3;MEF2A;SIRT2;EGR1;TRIP4;TP53
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22941347146739458,0.5756223059248291,0.9337016574585635,0.9847057970228832,1.0,8/27,19.10%,POLR2C;POLR3H;MED20;POLR1A;PRIM1;POLR1B;POLR3F;POLR2D
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21576008090546325,0.57290663613987,0.9422718808193669,0.9835721479675039,1.0,9/40,14.68%,FBLL1;AS3MT;PCMTD2;THUMPD2;PRMT7;SETD3;METTL18;SUV39H1;GAMT
prerank,carbohydrate kinase activity (GO:0019200),-0.2510568374160401,-0.5702987752068355,0.9347442680776014,0.9937948404228161,1.0,7/11,43.50%,HK2;GNE;HK1;KHK;GALK2;POMK;HK3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.21045641940660886,-0.5684704973456813,0.97265625,0.9916438579320459,1.0,2/23,5.85%,SESTD1;WIPI2
prerank,N-acyltransferase activity (GO:0016410),0.2244435656862609,0.5680073491911606,0.9457364341085271,0.9837082990564461,1.0,6/32,11.62%,BAAT;PLAAT1;CERS4;PLA2G4E;GLYAT;EP300
prerank,ATP hydrolysis activity (GO:0140603),0.2137737317981137,0.5678972615623363,0.975,0.9808284573454221,1.0,10/41,16.87%,ABCD2;TOR1B;ATAD1;DDX3X;RUVBL1;ABCB10;RHOBTB3;TOR1A;CHD1L;VWA8
prerank,RNA methyltransferase activity (GO:0008173),0.24953173564275047,0.5562803128904423,0.9320987654320988,0.9850229055684965,1.0,2/19,6.05%,FBLL1;TRMT5
prerank,single-stranded RNA binding (GO:0003727),0.2102908423469464,0.5560187518055131,0.9699248120300752,0.9822216121023895,1.0,14/43,21.26%,ADARB2;AGO3;DDX3X;HNRNPA1;RBM7;HNRNPU;FMR1;DDX11;LACTB2;ZFR;ENDOV;POLR2D;EIF4H;PTBP1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.21470846042782948,-0.5544979044170641,0.9702048417132216,0.9944224818985328,1.0,2/18,7.81%,GAS6;BIRC3
prerank,signal sequence binding (GO:0005048),-0.1877038459669999,-0.548688671289575,0.9848812095032398,0.9936054591148427,1.0,8/35,22.64%,CEMIP;BRAP;KPNA6;NFKBIA;BABAM2;SEC61A1;NUP214;AP2M1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.25704926616164525,0.5473347883445687,0.920997920997921,0.9840438843845677,1.0,3/11,17.45%,NAA11;NAA30;NAA15
prerank,3'-5' exonuclease activity (GO:0008408),0.20193328416562317,0.5408289449934416,0.969147005444646,0.9845772528359993,1.0,12/45,17.94%,REXO2;PAN2;XRN2;RAD1;TRIR;REV3L;EXD1;DIS3L2;TATDN1;ERI2;APEX1;USB1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.1935318387922365,-0.5389885601829049,0.9896049896049897,0.9939879910244488,1.0,13/28,39.93%,EDC3;PRORP;ELAC2;DICER1;RPP38;NUDT16;POP1;AGO2;EXO1;RPP21;FEN1;RPP40;MRPL44
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.21682047322522344,0.5357081761835286,0.9717171717171718,0.9840975833387547,1.0,6/28,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;MADD;TRIM37
prerank,gamma-tubulin binding (GO:0043015),0.21654331796405246,0.517101379296566,0.9577464788732394,0.9892049880758275,1.0,6/21,19.22%,DDX3X;BRSK1;ARHGEF7;PAK1;MARK4;NDRG1
prerank,ubiquitin binding (GO:0043130),-0.1513293288590546,-0.5130441318703438,1.0,0.9983203951744776,1.0,21/73,31.22%,SMAD3;TOM1L1;RNF185;USP5;DNAJB2;MDM2;SIRT2;NPLOC4;IKBKG;VPS28;UBE2L6;UBXN1;TOP2A;RNF19B;PRKN;NUP62;OTUB2;CXCR4;NEDD4;AUP1;HSPB1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.16625127261705636,-0.5126107669304567,0.9977116704805492,0.9955164909716995,1.0,6/42,15.89%,KAT2B;CCND2;CCND3;CCNG1;CCND1;CDKN1B
prerank,pseudouridine synthase activity (GO:0009982),0.23609541745134976,0.509946495603131,0.9546485260770975,0.989038922512377,1.0,13/13,76.41%,TRUB1;PUS7;DKC1;RPUSD1;PUS10;PUS1;PUSL1;PUS3;RPUSD3;RPUSD2;RPUSD4;PUS7L;TRUB2
prerank,aspartic-type peptidase activity (GO:0070001),-0.22584498192502672,-0.5069530772779649,0.974910394265233,0.993934826212548,1.0,3/10,31.84%,BACE2;CTSD;CTSE
prerank,transaminase activity (GO:0008483),0.2425291609079599,0.5061591610580718,0.9513742071881607,0.9875466032820422,1.0,2/11,10.85%,GOT1;PSAT1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2028931040204895,0.5056614168958194,0.9793621013133208,0.984898132197159,1.0,7/27,19.10%,POLR2C;POLR3H;MED20;POLR1A;POLR1B;POLR3F;POLR2D
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2334442282342603,0.4995204627962884,0.9572649572649573,0.984158404085858,1.0,12/12,76.67%,DHRS4;CRYZL1;CBR1;CRYZ;NQO1;CBR4;NQO2;ADH4;AKR1C1;AIFM2;DCXR;NDUFS7
prerank,snoRNA binding (GO:0030515),-0.166197982947841,-0.47860319965115006,0.9915966386554622,0.9967411904262328,1.0,11/30,36.27%,NUDT4;NOP58;UTP6;BYSL;NUDT16;NUDT1;NHP2;NUDT5;IMP4;BMS1;ISG20
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.19368058405183383,-0.46201809817281136,0.9963570127504554,0.9963425303924414,1.0,3/13,24.34%,ARHGDIA;SH3BP4;RANBP1
prerank,neuropeptide hormone activity (GO:0005184),0.18817913447647788,0.45510449821725635,0.9920477137176938,0.9935861197362457,1.0,22/22,81.21%,CCK;SPX;NPY;PNOC;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;NPFF;GAL;CRH;VIP;NMB;ADCYAP1;GRP;PENK;AGRP;PPY
prerank,ribonuclease P RNA binding (GO:0033204),0.21282872026611432,0.4496433749752877,0.9761904761904762,0.9917837424249286,1.0,10/10,78.73%,POP7;POP5;RPP30;POP4;RPP25;RPP14;RPP40;RPP21;POP1;RPP38
prerank,nuclear localization sequence binding (GO:0008139),-0.17446078555899297,-0.44573374605741123,1.0,0.9952919452520491,1.0,4/18,20.50%,BRAP;KPNA6;NFKBIA;NUP214
prerank,aspartic-type endopeptidase activity (GO:0004190),0.17167786077459046,0.3779323376376428,0.9958246346555324,0.9979417478929709,1.0,12/12,82.85%,PSEN1;HM13;SPPL3;SPPL2A;BACE1;PGC;DDI2;ASPRV1;NAPSA;SPPL2B;CTSE;BACE2
